Sepsa
Diagnostyka i diagnoza

Sepsa definiowana jest jako zagrażająca życiu dysfunkcja narządów spowodowana zaburzoną odpowiedzią organizmu na zakażenie, zgodnie z definicją Sepsis-3 z 2016 roku. Wstrząs septyczny charakteryzuje się utrzymującym się niedociśnieniem wymagającym wazopresorów do utrzymania średniego ciśnienia tętniczego ≥65 mmHg oraz stężeniem mleczanów w surowicy ≥2 mmol/L (18 mg/dL) pomimo odpowiedniego uzupełnienia płynów, co wiąże się z 30-40% śmiertelnością. Wczesne rozpoznanie sepsy jest kluczowe, gdyż każde opóźnienie wdrożenia antybiotykoterapii o godzinę zwiększa śmiertelność o 7,6-8% w ciągu pierwszych 6 godzin. Diagnostyka opiera się na ocenie klinicznej, badaniach laboratoryjnych (morfologia, biochemia, gazometria, koagulologia), biomarkerach (mleczany, prokalcytonina, CRP, IL-6) oraz badaniach mikrobiologicznych, w tym posiewach krwi i testach molekularnych. Skale oceny, takie jak SOFA (wzrost o ≥2 punkty) i qSOFA (≥2 z kryteriów: częstość oddechów ≥22/min, zaburzenia świadomości, skurczowe ciśnienie ≤100 mmHg), wspomagają identyfikację pacjentów z sepsą, choć mogą prowadzić do opóźnień w rozpoznaniu.

Definicja Sepsy

Sepsa (sepsis) jest stanem zagrożenia życia, charakteryzującym się dysfunkcją narządów spowodowaną zaburzeniem regulacji odpowiedzi organizmu na zakażenie. Bez natychmiastowego leczenia może prowadzić do uszkodzenia tkanek, niewydolności narządów i śmierci12. Współczesna definicja sepsy wprowadzona w 2016 roku (Sepsis-3) określa ją jako zagrażającą życiu dysfunkcję narządów spowodowaną zaburzoną odpowiedzią organizmu na zakażenie, odchodząc od wcześniejszego pojęcia zespołu ogólnoustrojowej reakcji zapalnej (SIRS)34.

Wstrząs septyczny stanowi podzbiór sepsy, w którym współistnieją:

  • Utrzymujące się niedociśnienie wymagające stosowania wazopresorów do utrzymania średniego ciśnienia tętniczego ≥65 mmHg
  • Stężenie mleczanów w surowicy ≥2 mmol/L (18 mg/dL) pomimo odpowiedniego uzupełnienia płynów5

Wstrząs septyczny wskazuje na głębokie zaburzenia krążeniowe, komórkowe i metaboliczne, które wiążą się z większym ryzykiem śmiertelności niż sama sepsa6. Śmiertelność we wstrząsie septycznym wynosi około 30-40%7.

Wczesne rozpoznanie sepsy – kluczowy element diagnostyki

Wczesne rozpoznanie sepsy ma kluczowe znaczenie dla poprawy wyników leczenia pacjentów. Z każdą godziną opóźnienia wdrożenia odpowiedniego leczenia antybiotykami wzrasta śmiertelność o około 7,6-8% w ciągu pierwszych 6 godzin od wystąpienia objawów89. Szacuje się, że nawet 80% zgonów z powodu sepsy można zapobiec poprzez szybką diagnostykę i leczenie1011.

Rozpoznanie sepsy jest często utrudnione z powodu niespecyficznych objawów i może nastąpić z opóźnieniem. Rozpoznanie sepsy powinno być podejrzewane u pacjentów z ostrym pogorszeniem stanu klinicznego, u których istnieją kliniczne dowody lub silne podejrzenie infekcji12. Lekarze powinni mieć niski próg podejrzenia sepsy i działać szybko, zanim stan pacjenta stanie się oczywisty z wieloma nieprawidłowymi parametrami fizjologicznymi, co wiąże się z bardzo wysokim ryzykiem śmiertelności13.

Kryteria diagnostyczne i skale oceny

Nie istnieją ścisłe kryteria pozwalające na jednoznaczne zdiagnozowanie sepsy. Lekarze stosują kombinację wyników badania fizykalnego, badań laboratoryjnych, zdjęć rentgenowskich i innych testów w celu identyfikacji infekcji i rozpoznania sepsy14. Obecnie stosowane są różne systemy oceny do rozpoznawania i stratyfikacji sepsy:

Skala SOFA (Sequential Organ Failure Assessment)

Zgodnie z definicją Sepsis-3, dysfunkcja narządów powinna być określana za pomocą skali SOFA (Sequential Organ Failure Assessment). Wzrost wyniku SOFA o co najmniej 2 punkty w stosunku do stanu wyjściowego oznacza dysfunkcję narządów i jest wykorzystywany do zdefiniowania sepsy1516. Skala SOFA ocenia następujące układy:

  • Układ oddechowy
  • Układ sercowo-naczyniowy
  • Wątroba
  • Nerki
  • Układ krzepnięcia
  • Ośrodkowy układ nerwowy1718

Skala qSOFA (quick SOFA)

Skala qSOFA została zaprojektowana w celu szybkiego rozpoznania możliwej sepsy w warunkach innych niż oddział intensywnej terapii19. Podejrzenie sepsy powinno być wysunięte u pacjentów spełniających co najmniej dwa z trzech kryteriów qSOFA:

Zaletami skali qSOFA są: możliwość szybkiego zastosowania, brak konieczności wykonywania badań laboratoryjnych oraz możliwość wykorzystania poza OIT21. Jednak Amerykańskie Kolegium Lekarzy Chorób Klatki Piersiowej (CHEST) wyraziło obawy, że kryteria qSOFA i SOFA mogą prowadzić do opóźnionego rozpoznania poważnej infekcji i opóźnionego leczenia22.

Inne systemy oceny

Poza skalami SOFA i qSOFA stosowane są również inne narzędzia do oceny ryzyka sepsy:

  • Kryteria SIRS (Systemic Inflammatory Response Syndrome) – nadal stosowane w niektórych ośrodkach mimo odejścia od tej definicji w Sepsis-323
  • NEWS2 (National Early Warning Score) – wysoki wynik (≥5) jest kluczowym czynnikiem diagnostycznym24
  • MEWS (Modified Early Warning Score)25
  • Wynik MEDS (Mortality in Emergency Department Sepsis) – służący do oszacowania śmiertelności26

Diagnostyka laboratoryjna sepsy

Diagnostyka laboratoryjna sepsy obejmuje szereg badań mających na celu potwierdzenie infekcji, ocenę dysfunkcji narządów i identyfikację patogenu wywołującego infekcję27. Do podstawowych badań laboratoryjnych zalicza się:

Podstawowe badania laboratoryjne

W diagnostyce sepsy wykorzystuje się następujące podstawowe badania:

  • Morfologia krwi z rozmazem – może wykazać podwyższoną lub obniżoną liczbę białych krwinek, niedokrwistość i/lub małopłytkowość28
  • Panel biochemiczny – ocena funkcji nerek i wątroby, elektrolity, glukoza29
  • Gazometria krwi tętniczej – do oceny równowagi kwasowo-zasadowej i utlenowania30
  • Badania koagulologiczne – ocena układu krzepnięcia31
  • Badanie ogólne moczu i posiew moczu – w przypadku podejrzenia infekcji układu moczowego32

Biomarkery sepsy

W diagnostyce sepsy stosowane są różne biomarkery, które pomagają w identyfikacji zakażenia i ocenie ciężkości stanu pacjenta. Do najważniejszych biomarkerów należą:

Stężenie mleczanów (kwasu mlekowego)

Stężenie mleczanów jest integralnym elementem diagnostyki, leczenia i prognozowania w sepsie33. Stężenie mleczanów >2 mmol/L (18 mg/dL) jest jednym z kryteriów diagnostycznych wstrząsu septycznego według definicji Sepsis-334. Wysokie stężenie mleczanów wiąże się z większym ryzykiem rozwoju jawnego wstrząsu septycznego i złym rokowaniem35. Brak zdolności do obniżenia stężenia mleczanów podczas leczenia sepsy powinien skłonić do ponownej oceny adekwatnej kontroli źródła zakażenia36.

Prokalcytonina (PCT)

Prokalcytonina jest markerem stanu zapalnego produkowanym przez cytokiny i bakteryjne endotoksyny, szeroko stosowanym jako wskaźnik zakażenia bakteryjnego w sepsie37. PCT jest obecnie jedynym testem zatwierdzonym przez FDA do wspomagania diagnostyki sepsy38. Jest to białko w krwi, którego poziom wzrasta w przypadku zakażenia bakteryjnego, choć nie może określić rodzaju zakażenia. Niskie poziomy PCT mogą skłonić lekarza do wykluczenia zakażenia bakteryjnego39.

Pomiary PCT mogą być wykorzystywane do:

  • Oceny czy pacjent ma sepsę i decyzji o rozpoczęciu antybiotykoterapii40
  • Monitorowania skuteczności leczenia41
  • Decyzji o bezpiecznym zakończeniu antybiotykoterapii42
  • Różnicowania sepsy od nieinfekcyjnych przyczyn stanu zapalnego43
Inne biomarkery

Oprócz mleczanów i prokalcytoniny, w diagnostyce sepsy stosowane są również inne biomarkery:

  • Białko C-reaktywne (CRP) – niespecyficzny marker stanu zapalnego44
  • Interleukina-6 (IL-6) – marker wczesnej odpowiedzi zapalnej45
  • Presepsyna – marker zakażenia bakteryjnego46
  • Endotoksyna – składnik niektórych bakterii uwalniany podczas rozpadu komórki bakteryjnej47
  • NT-proBNP – marker wstrząsu48
  • Parametry aktywacji białych krwinek – oferują informacje o wczesnej odpowiedzi immunologicznej49

Idealny biomarker sepsy powinien charakteryzować się wysoką czułością i swoistością, nadawać się do stosowania przy łóżku pacjenta i być opłacalny kosztowo50. Niestety, żaden z obecnie dostępnych biomarkerów nie posiada wystarczającej dokładności diagnostycznej do samodzielnego zastosowania w diagnostyce sepsy51.

Diagnostyka mikrobiologiczna

Diagnostyka mikrobiologiczna ma kluczowe znaczenie w identyfikacji patogenu powodującego infekcję i dostosowaniu antybiotykoterapii52. Obejmuje ona:

Posiewy krwi

Posiewy krwi są uważane za złoty standard w diagnostyce zakażeń krwi, w tym sepsy53. Zaleca się pobranie dwóch zestawów posiewów krwi (każdy zestaw obejmujący zarówno butelki do hodowli tlenowej, jak i beztlenowej) z dwóch różnych miejsc przed podaniem antybiotyków, aby zapewnić dokładną identyfikację patogenów i właściwe postępowanie medyczne54.

Jednak posiewy krwi mają pewne ograniczenia:

  • Są pozytywne tylko u 20-30% pacjentów z sepsą55
  • Wyniki są dostępne dopiero po 2-3 dniach56
  • U 30-50% pacjentów z sepsą nie udaje się zidentyfikować przyczyny za pomocą posiewów57
Inne badania mikrobiologiczne

Oprócz posiewów krwi, w diagnostyce sepsy stosowane są również inne badania mikrobiologiczne:

  • Posiewy z innych miejsc zakażenia (mocz, plwocina, płyn mózgowo-rdzeniowy, rany itp.)58
  • Badania molekularne – PCR (reakcja łańcuchowa polimerazy) umożliwiające szybką identyfikację patogenów59
  • Metagenomiczne sekwencjonowanie nowej generacji (mNGS) – umożliwiające wykrycie wszystkich fragmentów kwasów nukleinowych w próbce60
  • Spektrometria masowa MALDI-TOF – pozwalająca na szybką identyfikację gatunków bakterii61
  • Spektroskopia Ramana wzmocniona powierzchniowo (SERS)62

Badania obrazowe

Badania obrazowe są ważnym elementem diagnostyki sepsy, pomagając w identyfikacji źródła zakażenia63. W zależności od podejrzewanego źródła zakażenia można wykonać:

  • Rentgen klatki piersiowej – w przypadku podejrzenia zapalenia płuc64
  • USG – do oceny narządów jamy brzusznej, układu moczowego, serca65
  • Tomografia komputerowa (TK) – do dokładniejszej oceny narządów i tkanek66
  • Rezonans magnetyczny (MRI) – w wybranych przypadkach67

Nowoczesne metody diagnostyczne w sepsie

W ostatnich latach opracowano szereg nowoczesnych metod diagnostycznych mających na celu przyspieszenie i zwiększenie dokładności rozpoznania sepsy:

Testy genetyczne i molekularne

Testy genetyczne i molekularne umożliwiają szybką identyfikację patogenów i markerów sepsy:

  • Test SeptiCyte RAPID – wykorzystuje technologię PCR do analizy ekspresji genów w odpowiedzi immunologicznej gospodarza, umożliwiając odróżnienie sepsy od nieinfekcyjnej ogólnoustrojowej reakcji zapalnej (SIRS) w ciągu około godziny6869
  • Metagenomiczne sekwencjonowanie nowej generacji (mNGS) i uczenie maszynowe – pozwalające zidentyfikować 99% potwierdzonych przypadków bakteryjnej sepsy, 92% potwierdzonych przypadków wirusowej sepsy i przewidzieć sepsę w 74% klinicznie podejrzewanych przypadków70
  • Technologia profilowania transkryptomu – pozwalająca na analizę ekspresji genów gospodarza w odpowiedzi na infekcję71
  • Testy oparte na wolnym DNA we krwi – przyspieszające diagnozę patogenów wywołujących sepsę wraz z ich profilami oporności na antybiotyki72

Testy typu point-of-care

Testy point-of-care (przyłóżkowe) umożliwiają szybką diagnostykę sepsy bezpośrednio przy pacjencie:

  • IntelliSep – test krwi, który w ciągu około 8-10 minut dostarcza wyników stratyfikujących pacjentów na podstawie prawdopodobieństwa wystąpienia sepsy7374
  • Szybkie testy biomarkerów – umożliwiające szybką diagnostykę w warunkach oddziału ratunkowego i intensywnej terapii75
  • Testy przyłóżkowe prokalcytoniny – dostarczające wyników w około 20 minut76

Systemy oparte na sztucznej inteligencji (AI)

Systemy sztucznej inteligencji są coraz częściej wykorzystywane w diagnostyce sepsy:

  • Sepsis ImmunoScore – pierwszy zatwierdzony przez FDA diagnostyczny narzędzie AI do diagnostyki sepsy77
  • Modele uczenia maszynowego do analizy danych pacjentów i przewidywania ryzyka sepsy78
  • Algorytmy analizujące dane z elektronicznej dokumentacji medycznej w czasie rzeczywistym79

Strategia diagnostyczna w sepsie

Skuteczna strategia diagnostyczna w sepsie powinna być kompleksowa i obejmować następujące elementy:

Wczesna identyfikacja i ocena pacjentów z podejrzeniem sepsy

Kluczowym elementem jest wczesna identyfikacja pacjentów z podejrzeniem sepsy i szybka ocena ich stanu:

  • Stosowanie systemów wczesnego ostrzegania (np. NEWS2) do identyfikacji pacjentów z pogarszającym się stanem klinicznym80
  • Niska bariera podejrzenia sepsy u pacjentów z objawami infekcji81
  • Częste i regularne monitorowanie parametrów życiowych pacjentów z podejrzeniem sepsy82

Wstępna diagnostyka

W ciągu pierwszych trzech godzin od podejrzenia sepsy, badania diagnostyczne powinny obejmować:

  • Oznaczenie liczby białych krwinek
  • Pomiar stężenia mleczanów w surowicy
  • Pobranie odpowiednich posiewów przed rozpoczęciem antybiotykoterapii, o ile nie opóźnia to zastosowania antybiotyków o więcej niż 45 minut83

Pełna ocena diagnostyczna

Pełna ocena diagnostyczna powinna obejmować:

  • Kompleksowe badania laboratoryjne (morfologia, biochemia, koagulologia, biomarkery)
  • Posiewy krwi i innych płynów ustrojowych
  • Badania obrazowe w celu identyfikacji źródła zakażenia
  • Ocenę dysfunkcji narządów za pomocą skali SOFA84

Ciągła ocena i monitorowanie

Konieczne jest ciągłe monitorowanie stanu pacjenta i skuteczności leczenia:

  • Powtarzane pomiary stężenia mleczanów – jeśli początkowe stężenie przekracza 2 mmol/L, należy ponownie zmierzyć je w ciągu 2-4 godzin85
  • Monitorowanie parametrów życiowych i funkcji narządów
  • Powtarzane pomiary biomarkerów w celu oceny odpowiedzi na leczenie86

Wyzwania w diagnostyce sepsy

Diagnostyka sepsy wiąże się z licznymi wyzwaniami, które mogą utrudniać wczesne rozpoznanie i leczenie:

Niespecyficzne objawy i trudności w różnicowaniu

Objawy sepsy są często niespecyficzne i mogą przypominać inne stany chorobowe:

  • Sepsa może manifestować się różnorodnymi objawami klinicznymi, co utrudnia wczesne rozpoznanie87
  • Trudności w różnicowaniu sepsy od nieinfekcyjnych przyczyn ogólnoustrojowej reakcji zapalnej88
  • Nakładanie się objawów klinicznych między sepsą a innymi stanami nieinfekcyjnymi89

Brak idealnego testu diagnostycznego

Mimo postępów w diagnostyce sepsy, nadal brakuje idealnego testu diagnostycznego:

  • Nie istnieje pojedynczy test umożliwiający jednoznaczne rozpoznanie sepsy90
  • Posiewy krwi są często negatywne mimo klinicznych dowodów sepsy91
  • Żaden z biomarkerów nie ma wystarczającej swoistości i czułości, aby mógł być stosowany samodzielnie w diagnostyce sepsy92

Czas uzyskania wyników badań

Czas potrzebny do uzyskania wyników badań może opóźniać diagnozę i leczenie:

  • Tradycyjne metody hodowli mogą zajmować dni, a śmiertelność może wzrastać nawet o 8% za każdą godzinę opóźnienia skutecznej antybiotykoterapii93
  • Czas potrzebny do potwierdzenia zakażenia i identyfikacji patogenu może być zbyt długi w kontekście sepsy94
  • Opóźnienie w diagnostyce prowadzi do opóźnienia w rozpoczęciu właściwego leczenia95

Oporność na antybiotyki

Rosnąca oporność na antybiotyki stanowi poważne wyzwanie w leczeniu sepsy:

  • Szybkie pojawienie się opornych mikroorganizmów doprowadziło do kryzysu oporności na antybiotyki96
  • Zakażenia opornymi patogenami zwiększają śmiertelność w sepsie97
  • Konieczność stosowania racjonalnej antybiotykoterapii przy jednoczesnym zapewnieniu skutecznego leczenia sepsy98

Znaczenie wczesnej diagnostyki dla wyników leczenia

Wczesna i dokładna diagnostyka sepsy ma kluczowe znaczenie dla poprawy wyników leczenia pacjentów:

Wpływ na śmiertelność

Wczesna diagnostyka i leczenie istotnie wpływają na śmiertelność pacjentów z sepsą:

  • Każda godzina opóźnienia wdrożenia antybiotyków zwiększa śmiertelność o 7,6-8% w ciągu pierwszych 6 godzin99
  • Szacuje się, że do 80% zgonów z powodu sepsy można zapobiec poprzez wczesną diagnostykę i leczenie100
  • Dostarczenie odpowiednich antybiotyków w ciągu pierwszej godziny od rozpoznania sepsy zmniejsza ryzyko zgonu101

Opieka zgodna z wytycznymi

Przestrzeganie wytycznych i formalnych protokołów dotyczących wczesnej diagnostyki i leczenia sepsy wykazało zmniejszenie śmiertelności i skrócenie pobytu w szpitalu102. Kluczowe elementy opieki obejmują:

Postępowanie „Sepsis Six” w ciągu pierwszej godziny od rozpoznania sepsy:

  • Tlenoterapia – rozpoczęcie tlenoterapii przy użyciu maski tlenowej z docelowym wysyceniem 94-98%
  • Płynoterapia dożylna – początkowy bolus 500-1000 ml, a następnie ciągła ocena stanu nawodnienia
  • Posiewy krwi – pobranie posiewów krwi przed podaniem antybiotyków
  • Antybiotyki dożylne – rozpoczęcie empirycznej antybiotykoterapii zgodnie z lokalnymi wytycznymi
  • Badania laboratoryjne – morfologia, parametry biochemiczne, CRP, mleczany
  • Monitorowanie diurezy – cewnikowanie pacjenta i dokładne monitorowanie diurezy103

Przeprowadzenie tego protokołu w ciągu godziny od rozpoznania sepsy wykazało zmniejszenie względnego ryzyka zgonu o 46,6%104.

Właściwa antybiotykoterapia

Szybkie wdrożenie odpowiedniej antybiotykoterapii jest kluczowe w leczeniu sepsy:

  • Natychmiastowe rozpoczęcie antybiotykoterapii jest jedną z najskuteczniejszych interwencji zmniejszających zachorowalność i śmiertelność związaną z sepsą105
  • Wytyczne zalecają rozpoczęcie antybiotykoterapii w ciągu godziny, choć jest to kwestia kontrowersyjna106
  • 5-krotne zmniejszenie przeżywalności w przypadku nieodpowiedniej początkowej antybiotykoterapii we wstrząsie septycznym, co występuje u około 20% pacjentów107

Kontrola źródła zakażenia

Identyfikacja i kontrola źródła zakażenia są istotne dla skutecznego leczenia sepsy:

  • Jeśli źródło nie zostanie opanowane, stan pacjenta będzie się pogarszać pomimo antybiotykoterapii108
  • Źródło zakażenia należy kontrolować jak najwcześniej109
  • W niektórych przypadkach konieczne jest leczenie chirurgiczne w celu usunięcia źródeł zakażenia, takich jak ropnie, zakażone tkanki lub martwicze tkanki110

Podsumowanie

Diagnostyka sepsy jest złożonym procesem, który wymaga kompleksowego podejścia łączącego ocenę kliniczną, badania laboratoryjne, diagnostykę mikrobiologiczną i obrazowanie. Kluczowe znaczenie ma wczesne rozpoznanie i szybkie wdrożenie odpowiedniego leczenia, co może znacząco zmniejszyć śmiertelność pacjentów z sepsą.

Mimo postępów w diagnostyce sepsy, nadal nie istnieje pojedynczy test o wystarczającej dokładności do jednoznacznego rozpoznania tego stanu. Dlatego najlepszym podejściem jest wykorzystanie kombinacji oceny klinicznej, systemów punktacji (SOFA, qSOFA), biomarkerów (mleczany, prokalcytonina) i badań mikrobiologicznych.

Nowoczesne metody diagnostyczne, takie jak testy molekularne, metagenomiczne sekwencjonowanie nowej generacji czy systemy oparte na sztucznej inteligencji, oferują obiecujące możliwości przyspieszenia i zwiększenia dokładności diagnostyki sepsy. Jednak ich praktyczne zastosowanie wymaga dalszych badań i walidacji.

Należy pamiętać, że sepsa jest stanem zagrożenia życia, który wymaga natychmiastowego działania. W przypadku podejrzenia sepsy, lepiej jest rozpocząć leczenie empiryczne i kontynuować diagnostykę równolegle, niż czekać na pełne potwierdzenie diagnozy przed wdrożeniem leczenia.

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 10.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Sepsis: Symptoms, Causes, Treatment & Prevention
    https://my.clevelandclinic.org/health/diseases/12361-sepsis
    Sepsis is a life-threatening medical emergency caused by your body’s overwhelming response to an infection. Without urgent treatment, it can lead to tissue damage, organ failure and death. […] It’s very important to quickly identify people with infections that may go on to develop sepsis. There are no strict criteria to diagnose sepsis. That’s why providers use a combination of findings from a physical exam, lab tests, X-rays and other tests to identify the infection (blood cultures) and diagnose sepsis. […] If your provider diagnoses you with sepsis, they’ll usually place you in the intensive care unit (ICU) of the hospital for special treatment. You may receive the following treatment for sepsis: Antibiotics: You’ll receive antibiotics if you have a bacterial infection. […] Sepsis is a life-threatening medical emergency. To avoid sepsis, make sure to get treatment for any infections immediately. If you delay treatment, a simple infection could lead to a deadly condition.
  • #2 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    Guidelines published in 2016 provide a revised definition of sepsis: life-threatening organ dysfunction caused by a dysregulated host response to infection. […] The guidelines recommend the Sequential Organ Failure Assessment (original and quick versions) as an important tool for early diagnosis. […] Initial evaluation of patients with suspected sepsis includes basic laboratory tests, cultures, imaging studies as indicated, and sepsis biomarkers such as procalcitonin and lactate levels. […] The latest guidelines recommend starting antimicrobials within one hour, but this is controversial. […] Sepsis is now defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. […] Septic shock is defined as sepsis with circulatory, cellular, and metabolic dysfunction that is associated with a higher risk of mortality.
  • #3 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Sepsis should be suspected in an acutely deteriorating patient in whom there is clinical evidence or strong suspicion of infection. Have a low threshold for suspicion. […] The key to improving outcomes is early recognition and prompt treatment, as appropriate, of patients with suspected or confirmed infection who are deteriorating and at risk of organ dysfunction. By the time the diagnosis becomes obvious, with multiple abnormal physiological parameters, risk of mortality is very high. […] Ensure any patient with suspected sepsis has frequent and ongoing monitoring (e.g., using NEWS2). […] Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection. […] The definition of sepsis was updated in 2016 following publication of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
  • #4 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    This recommended that organ dysfunction should be defined using the Sequential (or Sepsis-related) Organ Failure Assessment (SOFA) criteria or the 'quick’ (q)SOFA criteria. […] The 2016 consensus definitions marked a shift away from the previous systemic inflammatory response syndrome (SIRS) definition, which classified sepsis as two or more of the following in the context of infection. […] However, the 2016 Third International Consensus Group (Sepsis-3) definitions state that the term 'severe sepsis’ should be made redundant in light of the revisions to the definition of sepsis. […] Septic shock has also been redefined as a subset of sepsis, in which there is co-existence of: persistent hypotension requiring vasopressors to maintain mean arterial pressure 65 mmHg; and serum lactate 2 mmol/L (18 mg/dL).
  • #5 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    This recommended that organ dysfunction should be defined using the Sequential (or Sepsis-related) Organ Failure Assessment (SOFA) criteria or the 'quick’ (q)SOFA criteria. […] The 2016 consensus definitions marked a shift away from the previous systemic inflammatory response syndrome (SIRS) definition, which classified sepsis as two or more of the following in the context of infection. […] However, the 2016 Third International Consensus Group (Sepsis-3) definitions state that the term 'severe sepsis’ should be made redundant in light of the revisions to the definition of sepsis. […] Septic shock has also been redefined as a subset of sepsis, in which there is co-existence of: persistent hypotension requiring vasopressors to maintain mean arterial pressure 65 mmHg; and serum lactate 2 mmol/L (18 mg/dL).
  • #6 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Septic shock indicates profound circulatory, cellular, and metabolic deterioration, and is associated with a greater risk of mortality than with sepsis alone. […] High early warning score (e.g., NEWS2 5 or more) is a key diagnostic factor. […] Initial investigations to order include blood cultures, serum lactate, and hourly urine output.
  • #7 Sepsis and Septic Shock – Critical Care Medicine – MSD Manual Professional Edition
    https://www.msdmanuals.com/professional/critical-care-medicine/sepsis-and-septic-shock/sepsis-and-septic-shock
    The SOFA score is somewhat more robust when patients are treated in the ICU, but this score requires laboratory testing. […] Following evidence-based guidelines and formal protocols for timely diagnosis and treatment of sepsis has been shown to decrease mortality and length of stay in the hospital. […] The source of infection should be controlled as early as possible. […] If the source is not controlled, the patients condition will continue to deteriorate despite antibiotic therapy. […] Overall mortality in patients with septic shock is decreasing and is about 20%. […] Poor outcomes often follow failure to institute early aggressive therapy. […] Mortality can be estimated with different scores, including the mortality in emergency department sepsis (MEDS) score.
  • #8 Sepsis Management | BD
    https://www.bd.com/en-us/products-and-solutions/solutions/sepsis-management
    Mortality from septic shock increases 7.6% for every hour that treatment is delayed among patients with septic shock within the first 6 hours of onset of hypotension. The timely identification of a patient at risk for sepsis is necessary for setting the course of action to intervene with appropriate diagnosis and treatment. […] 80% of sepsis deaths could be prevented by quicker diagnosis and treatment. Decrease time to detection, followed by timely and accurate organism identification (ID) and antimicrobial susceptibility testing (AST). Reduction in transport time and faster incubation of blood cultures has been shown to reduce turnaround times and accelerate antibiotic switching. […] 5x reduction in survival when inappropriate initial antimicrobial therapy is performed for septic shock, which occurs in ~20% of patients. Ensuring that appropriate diagnostics are performed as early as possible to enable timely and appropriate antimicrobial therapy treatment decisions.
  • #9 Exploring the importance and challenges of early sepsis diagnosis • healthcare-in-europe.com
    https://healthcare-in-europe.com/en/news/exploring-the-importance-challenges-of-early-sepsis-diagnosis.html
    „Sepsis is one of the most deadly and costly medical conditions physicians and hospitals must face. In fact, statistics show that sepsis is the third leading cause of death in the U.S. Mortality rates for sepsis is extremely high approximately 25-30% with more individuals dying of sepsis than prostate cancer, breast cancer, and HIV combined. Early detection of sepsis is critical, as a delay in antibiotic treatment has been documented to result in increased mortality, with a 7.6% increase in death for patients with severe sepsis and septic shock every hour antibiotic administration is delayed. Therefore, the earlier sepsis is recognized and the earlier the treatment starts, the better the outcome for the patient and the lower the cost that can be expected to be borne by the healthcare system.”
  • #10 IntelliSep Sepsis Test – Cytovale
    https://cytovale.com/our-solution/intellisep-sepsis-test/
    Sepsis is a Medical Emergency that is Common, Costly, and Difficult to Diagnose. Misdiagnosis and delayed treatment may lead to serious consequences for patients and hospitals. 80% of sepsis deaths could be prevented with a rapid sepsis test that aids in sepsis diagnosis. […] Unlike Other Time-Sensitive Medical Emergencies, Sepsis Lacked a Highly Sensitive Diagnostic Test. Until Now. Like heart attack and stroke, there is now an objective detection tool for sepsis, supporting rapid diagnosis and treatment. […] IntelliSep is an In Vitro Diagnostic Test for Sepsis with Clear, Actionable Results. In about 8 minutes IntelliSep delivers clinically actionable results, risk-stratifying patients based on their probability of having sepsis. Results are presented as a numerical value between 0.1 and 10.0, which is further stratified into 3 discrete bands. Patients with sepsis typically have higher scores and fall into Band 3. IntelliSep helps the ED accelerate the time to diagnosis and treatment, patient disposition, and throughput.
  • #11 Diagnosing & Treating Sepsis: The Need for Speed | bioMérieux Living Diagnostics Blog
    https://www.biomerieux.com/corp/en/blog/sepsis/Diagnosing-Treating-Sepsis-Need-Speed.html
    Throughout this process, periodically checking PCT levels can help clinicians monitor whether treatment is working and decide when it is safe to stop antibiotic therapy. […] Ultimately, as many as 80% of sepsis deaths could be prevented through early identification and swift initiation of appropriate treatment.
  • #12 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Sepsis should be suspected in an acutely deteriorating patient in whom there is clinical evidence or strong suspicion of infection. Have a low threshold for suspicion. […] The key to improving outcomes is early recognition and prompt treatment, as appropriate, of patients with suspected or confirmed infection who are deteriorating and at risk of organ dysfunction. By the time the diagnosis becomes obvious, with multiple abnormal physiological parameters, risk of mortality is very high. […] Ensure any patient with suspected sepsis has frequent and ongoing monitoring (e.g., using NEWS2). […] Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection. […] The definition of sepsis was updated in 2016 following publication of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
  • #13 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Sepsis should be suspected in an acutely deteriorating patient in whom there is clinical evidence or strong suspicion of infection. Have a low threshold for suspicion. […] The key to improving outcomes is early recognition and prompt treatment, as appropriate, of patients with suspected or confirmed infection who are deteriorating and at risk of organ dysfunction. By the time the diagnosis becomes obvious, with multiple abnormal physiological parameters, risk of mortality is very high. […] Ensure any patient with suspected sepsis has frequent and ongoing monitoring (e.g., using NEWS2). […] Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection. […] The definition of sepsis was updated in 2016 following publication of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
  • #14 Sepsis: Symptoms, Causes, Treatment & Prevention
    https://my.clevelandclinic.org/health/diseases/12361-sepsis
    Sepsis is a life-threatening medical emergency caused by your body’s overwhelming response to an infection. Without urgent treatment, it can lead to tissue damage, organ failure and death. […] It’s very important to quickly identify people with infections that may go on to develop sepsis. There are no strict criteria to diagnose sepsis. That’s why providers use a combination of findings from a physical exam, lab tests, X-rays and other tests to identify the infection (blood cultures) and diagnose sepsis. […] If your provider diagnoses you with sepsis, they’ll usually place you in the intensive care unit (ICU) of the hospital for special treatment. You may receive the following treatment for sepsis: Antibiotics: You’ll receive antibiotics if you have a bacterial infection. […] Sepsis is a life-threatening medical emergency. To avoid sepsis, make sure to get treatment for any infections immediately. If you delay treatment, a simple infection could lead to a deadly condition.
  • #15 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    Guidelines published in 2016 provide a revised definition of sepsis: life-threatening organ dysfunction caused by a dysregulated host response to infection. […] The guidelines recommend the Sequential Organ Failure Assessment (original and quick versions) as an important tool for early diagnosis. […] Initial evaluation of patients with suspected sepsis includes basic laboratory tests, cultures, imaging studies as indicated, and sepsis biomarkers such as procalcitonin and lactate levels. […] The latest guidelines recommend starting antimicrobials within one hour, but this is controversial. […] Sepsis is now defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. […] Septic shock is defined as sepsis with circulatory, cellular, and metabolic dysfunction that is associated with a higher risk of mortality.
  • #16 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    This recommended that organ dysfunction should be defined using the Sequential (or Sepsis-related) Organ Failure Assessment (SOFA) criteria or the 'quick’ (q)SOFA criteria. […] The 2016 consensus definitions marked a shift away from the previous systemic inflammatory response syndrome (SIRS) definition, which classified sepsis as two or more of the following in the context of infection. […] However, the 2016 Third International Consensus Group (Sepsis-3) definitions state that the term 'severe sepsis’ should be made redundant in light of the revisions to the definition of sepsis. […] Septic shock has also been redefined as a subset of sepsis, in which there is co-existence of: persistent hypotension requiring vasopressors to maintain mean arterial pressure 65 mmHg; and serum lactate 2 mmol/L (18 mg/dL).
  • #17 Laboratory Evaluation of Sepsis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK594258/
    Sepsis is evaluated with various laboratory studies, including different biomarkers essential for diagnosis, early recognition of severity, risk stratification, and prognosis. These studies also have a role in dictating management and antibiotic stewardship. The initial management of a patient with suspected sepsis includes evaluation for the source of infection, severity assessment, treatment and prevention of hypotension, intravenous fluids, vasopressors, antibiotics, and infection source control. The severity of sepsis is determined through physical examination and laboratory evaluation. […] The laboratory workup for patients with suspected sepsis includes blood lactate, complete blood count with differential (CBC), chemistry panel, and liver function tests (LFTs). Using this laboratory data, along with clinical findings, is essential in stratifying the severity of the disease. The SOFA score is used to define sepsis and has prognostic and therapeutic value. This scoring system allows clinicians to assess organ dysfunction, the characterizing feature of sepsis and septic shock, and evaluates the respiratory, cardiovascular, hepatic, renal, hematologic, and central nervous systems.
  • #18 Laboratory Evaluation of Sepsis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK594258/
    In addition to cultures and testing to identify causative pathogens, diagnostic tests used in evaluating sepsis include those that have proven utility in identifying systemic inflammatory response syndrome (SIRS) and organ dysfunction. These tests usually include the CBC, clinical chemistry, and arterial blood gas. Host-response and pathogen-specific biomarkers have been described in the literature as having utility in staging disease severity, prognosis, and response to treatment. Some common host-response biomarkers used in regular practice include C-reactive protein (CRP), lactate, and procalcitonin (PCT). […] The SOFA score assesses organ dysfunction, and most of the data required to calculate an accurate SOFA score is readily available through clinical assessment and commonly performed laboratory testing. An important limitation of the SOFA criteria is the scoring of respiratory dysfunction, which requires a PaO2 value to obtain the PaO2/FiO2 ratio.
  • #19 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    The qSOFA was designed to help clinicians recognize possible sepsis in settings other than the ICU. […] Sepsis should be suspected in patients meeting at least two of the three qSOFA criteria: respiratory rate of 22 breaths per minute or greater, altered mental status, and systolic blood pressure of 100 mm Hg or less. […] The full SOFA has been endorsed by the Society of Critical Care Medicine and is used in the ICU to predict in-hospital mortality. […] To improve the diagnosis of sepsis, clinicians must obtain historical, clinical, laboratory, and radiographic data supportive of infection and organ dysfunction. […] Laboratory testing should include a complete blood count with differential; basic metabolic panel; lactate, procalcitonin, and liver enzyme measurements; coagulation studies; and urinalysis.
  • #20 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    The qSOFA was designed to help clinicians recognize possible sepsis in settings other than the ICU. […] Sepsis should be suspected in patients meeting at least two of the three qSOFA criteria: respiratory rate of 22 breaths per minute or greater, altered mental status, and systolic blood pressure of 100 mm Hg or less. […] The full SOFA has been endorsed by the Society of Critical Care Medicine and is used in the ICU to predict in-hospital mortality. […] To improve the diagnosis of sepsis, clinicians must obtain historical, clinical, laboratory, and radiographic data supportive of infection and organ dysfunction. […] Laboratory testing should include a complete blood count with differential; basic metabolic panel; lactate, procalcitonin, and liver enzyme measurements; coagulation studies; and urinalysis.
  • #21 Sepsis – Wikipedia
    https://en.wikipedia.org/wiki/Sepsis
    In 2016 a new consensus was reached to replace screening by systemic inflammatory response syndrome (SIRS) with the sequential organ failure assessment (SOFA score) and the abbreviated version (qSOFA). […] Sepsis is suspected when 2 of the qSOFA criteria are met. […] The SOFA score was intended to be used in the intensive care unit (ICU) where it is administered upon admission to the ICU and then repeated every 48 hours, whereas the qSOFA could be used outside the ICU. […] Some advantages of the qSOFA score are that it can be administered quickly and does not require labs. […] However, the American College of Chest Physicians (CHEST) raised concerns that qSOFA and SOFA criteria may lead to delayed diagnosis of serious infection, leading to delayed treatment. […] Although SIRS criteria can be too sensitive and not specific enough in identifying sepsis, SOFA also has its limitations and is not intended to replace the SIRS definition.
  • #22 Sepsis – Wikipedia
    https://en.wikipedia.org/wiki/Sepsis
    In 2016 a new consensus was reached to replace screening by systemic inflammatory response syndrome (SIRS) with the sequential organ failure assessment (SOFA score) and the abbreviated version (qSOFA). […] Sepsis is suspected when 2 of the qSOFA criteria are met. […] The SOFA score was intended to be used in the intensive care unit (ICU) where it is administered upon admission to the ICU and then repeated every 48 hours, whereas the qSOFA could be used outside the ICU. […] Some advantages of the qSOFA score are that it can be administered quickly and does not require labs. […] However, the American College of Chest Physicians (CHEST) raised concerns that qSOFA and SOFA criteria may lead to delayed diagnosis of serious infection, leading to delayed treatment. […] Although SIRS criteria can be too sensitive and not specific enough in identifying sepsis, SOFA also has its limitations and is not intended to replace the SIRS definition.
  • #23 Exploring the importance and challenges of early sepsis diagnosis • healthcare-in-europe.com
    https://healthcare-in-europe.com/en/news/exploring-the-importance-challenges-of-early-sepsis-diagnosis.html
    „Diagnosing sepsis early is very challenging, because symptoms may not be obvious and clear at the time at which the patient presents at the hospital.” […] „Practically speaking, clinicians may use SIRS criteria (if they are still using sepsis-2) or the SOFA score (sequential organ failure assessment, if they use the sepsis-3 definition) to diagnose sepsis. Additionally, laboratory tests are used to test for infection and help confirm a suspicion of sepsis; for example, by measuring the patient’s WBC (white blood cell) count, Procalcitonin, C-Reactive Protein, Interleukin-6 or presepsin levels, or culturing body fluids such as blood or urine for infectious organisms. While positive cultures may be diagnostic of infection, none of these tests can definitively confirm a diagnosis of sepsis, so clinicians must rely on all the clinical and laboratory information available together to diagnose sepsis.”
  • #24 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Septic shock indicates profound circulatory, cellular, and metabolic deterioration, and is associated with a greater risk of mortality than with sepsis alone. […] High early warning score (e.g., NEWS2 5 or more) is a key diagnostic factor. […] Initial investigations to order include blood cultures, serum lactate, and hourly urine output.
  • #25 Laboratory Evaluation of Sepsis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK594258/
    Identifying sepsis and septic shock can prove problematic on initial presentation. The clinical presentation of sepsis is highly variable, the differential diagnosis of sepsis is exceedingly broad, and the underlying etiology of the presenting symptoms may not be immediately evident. […] Various screening tools for sepsis are used depending on the location of the evaluation. Most of these tools utilize criteria incorporating clinical evaluation, vital signs, and laboratory data to screen for sepsis and predict mortality. Some tools commonly used to screen for sepsis include the Systemic Inflammatory Response Syndrome (SIRS) criteria, quick Sequential Organ Failure Score (qSOFA), Sequential Organ Failure Assessment (SOFA) criteria, National Early Warning Score (NEWS), and Modified Early Warning Score (MEWS).
  • #26 Sepsis and Septic Shock – Critical Care Medicine – MSD Manual Professional Edition
    https://www.msdmanuals.com/professional/critical-care-medicine/sepsis-and-septic-shock/sepsis-and-septic-shock
    The SOFA score is somewhat more robust when patients are treated in the ICU, but this score requires laboratory testing. […] Following evidence-based guidelines and formal protocols for timely diagnosis and treatment of sepsis has been shown to decrease mortality and length of stay in the hospital. […] The source of infection should be controlled as early as possible. […] If the source is not controlled, the patients condition will continue to deteriorate despite antibiotic therapy. […] Overall mortality in patients with septic shock is decreasing and is about 20%. […] Poor outcomes often follow failure to institute early aggressive therapy. […] Mortality can be estimated with different scores, including the mortality in emergency department sepsis (MEDS) score.
  • #27 Laboratory Evaluation of Sepsis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK594258/
    Sepsis is evaluated with various laboratory studies, including different biomarkers essential for diagnosis, early recognition of severity, risk stratification, and prognosis. These studies also have a role in dictating management and antibiotic stewardship. The initial management of a patient with suspected sepsis includes evaluation for the source of infection, severity assessment, treatment and prevention of hypotension, intravenous fluids, vasopressors, antibiotics, and infection source control. The severity of sepsis is determined through physical examination and laboratory evaluation. […] The laboratory workup for patients with suspected sepsis includes blood lactate, complete blood count with differential (CBC), chemistry panel, and liver function tests (LFTs). Using this laboratory data, along with clinical findings, is essential in stratifying the severity of the disease. The SOFA score is used to define sepsis and has prognostic and therapeutic value. This scoring system allows clinicians to assess organ dysfunction, the characterizing feature of sepsis and septic shock, and evaluates the respiratory, cardiovascular, hepatic, renal, hematologic, and central nervous systems.
  • #28 Bacterial Sepsis: Practice Essentials, Background, Etiology
    https://emedicine.medscape.com/article/234587-overview
    A diagnosis of sepsis is based on a detailed history, physical examination, laboratory and microbiology testing, and imaging studies. Laboratory studies that may be considered include the following: Complete blood count (CBC) – May show elevated or low white blood cell count, anemia, and/or thrombocytopenia; Chemistry studies, such as markers of liver or kidney injury – May suggest organ dysfunction; Bacterial cultures – Blood cultures and site-specific cultures based on clinical suspicion (eg, wound culture, sputum culture, or urine culture); Stained buffy coat smears or Gram staining of peripheral blood – May be helpful in certain infections; Urine studies (urinalysis, microscopy, urine culture); Certain biomarkers, such as procalcitonin and presepsin – May be useful in diagnosing early sepsis and in determining prognosis. […] Early identification scores, including NEWS, Modified Early Warning Score (MEWS), and SIRS, demonstrate greater reliability and predictive capability compared to the qSOFA.
  • #29 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    The qSOFA was designed to help clinicians recognize possible sepsis in settings other than the ICU. […] Sepsis should be suspected in patients meeting at least two of the three qSOFA criteria: respiratory rate of 22 breaths per minute or greater, altered mental status, and systolic blood pressure of 100 mm Hg or less. […] The full SOFA has been endorsed by the Society of Critical Care Medicine and is used in the ICU to predict in-hospital mortality. […] To improve the diagnosis of sepsis, clinicians must obtain historical, clinical, laboratory, and radiographic data supportive of infection and organ dysfunction. […] Laboratory testing should include a complete blood count with differential; basic metabolic panel; lactate, procalcitonin, and liver enzyme measurements; coagulation studies; and urinalysis.
  • #30 Laboratory Evaluation of Sepsis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK594258/
    In addition to cultures and testing to identify causative pathogens, diagnostic tests used in evaluating sepsis include those that have proven utility in identifying systemic inflammatory response syndrome (SIRS) and organ dysfunction. These tests usually include the CBC, clinical chemistry, and arterial blood gas. Host-response and pathogen-specific biomarkers have been described in the literature as having utility in staging disease severity, prognosis, and response to treatment. Some common host-response biomarkers used in regular practice include C-reactive protein (CRP), lactate, and procalcitonin (PCT). […] The SOFA score assesses organ dysfunction, and most of the data required to calculate an accurate SOFA score is readily available through clinical assessment and commonly performed laboratory testing. An important limitation of the SOFA criteria is the scoring of respiratory dysfunction, which requires a PaO2 value to obtain the PaO2/FiO2 ratio.
  • #31 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    The qSOFA was designed to help clinicians recognize possible sepsis in settings other than the ICU. […] Sepsis should be suspected in patients meeting at least two of the three qSOFA criteria: respiratory rate of 22 breaths per minute or greater, altered mental status, and systolic blood pressure of 100 mm Hg or less. […] The full SOFA has been endorsed by the Society of Critical Care Medicine and is used in the ICU to predict in-hospital mortality. […] To improve the diagnosis of sepsis, clinicians must obtain historical, clinical, laboratory, and radiographic data supportive of infection and organ dysfunction. […] Laboratory testing should include a complete blood count with differential; basic metabolic panel; lactate, procalcitonin, and liver enzyme measurements; coagulation studies; and urinalysis.
  • #32 Azthena logo with the word Azthena
    https://www.news-medical.net/health/Sepsis-Diagnosis.aspx
    Some of the different tests that are needed to make a sepsis diagnosis include a urine test, blood test, and tests related to other medical conditions. […] For patients with possible signs of sepsis, there are a number of blood tests that can be utilized. Even though these tests cannot diagnose sepsis, combining the results with other information can help. […] There are three types of blood tests that can confirm sepsis, which include: Endotoxin test, Procalcitonin (PCT) test, SeptiCyte test. […] Two types of urine tests are ordered in cases of sepsis, which include: Urinalysis, Urine culture. […] Apart from blood and urine tests, additional tests that are related to other diseases that can cause sepsis are also performed.
  • #33 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    Procalcitonin is a marker for inflammation produced by cytokines and bacterial endotoxins and is widely used as an indicator for bacterial sepsis. […] Serum lactate level is also integral to the diagnosis, treatment, and prognosis of sepsis. […] A lactate level greater than 18 mg per dL (2 mmol per L) is a diagnostic criterion for septic shock in Sepsis-3. […] The inability to clear lactate during sepsis management should prompt reevaluation of adequate source control.
  • #34 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    Procalcitonin is a marker for inflammation produced by cytokines and bacterial endotoxins and is widely used as an indicator for bacterial sepsis. […] Serum lactate level is also integral to the diagnosis, treatment, and prognosis of sepsis. […] A lactate level greater than 18 mg per dL (2 mmol per L) is a diagnostic criterion for septic shock in Sepsis-3. […] The inability to clear lactate during sepsis management should prompt reevaluation of adequate source control.
  • #35 Sepsis | Choose the Right Test
    https://arupconsult.com/content/sepsis
    Increases in serum lactate concentrations are associated with a higher risk of developing overt septic shock and poor outcome in general. An initial measurement of serum lactate is recommended to guide resuscitation. […] Two sets of blood cultures (each set including both aerobic and anaerobic bottles) should be obtained from two different sites before administering antibiotics to ensure accurate identification of pathogens and proper medical management of infection. […] Procalcitonin (PCT) is an acute phase reactant (inflammatory marker) that is used as a biomarker for the risk assessment of progression to severe sepsis or septic shock and can help inform decisions on the duration of antibiotic treatment. Initial PCT concentrations on the first day of admission to the intensive care unit (ICU) may be used to aid in the assessment of risk for progression to severe sepsis and septic shock. A PCT concentration should be taken shortly after admission to the ICU to establish a baseline to monitor treatment response.
  • #36 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    Procalcitonin is a marker for inflammation produced by cytokines and bacterial endotoxins and is widely used as an indicator for bacterial sepsis. […] Serum lactate level is also integral to the diagnosis, treatment, and prognosis of sepsis. […] A lactate level greater than 18 mg per dL (2 mmol per L) is a diagnostic criterion for septic shock in Sepsis-3. […] The inability to clear lactate during sepsis management should prompt reevaluation of adequate source control.
  • #37 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    Procalcitonin is a marker for inflammation produced by cytokines and bacterial endotoxins and is widely used as an indicator for bacterial sepsis. […] Serum lactate level is also integral to the diagnosis, treatment, and prognosis of sepsis. […] A lactate level greater than 18 mg per dL (2 mmol per L) is a diagnostic criterion for septic shock in Sepsis-3. […] The inability to clear lactate during sepsis management should prompt reevaluation of adequate source control.
  • #38 Laboratory diagnosis of sepsis
    https://acutecaretesting.org/en/journal-scans/laboratory-diagnosis-of-sepsis
    PCT is currently the only FDA-approved test to aid in the diagnosis of sepsis, and raised lactate (2 mmol/L) is now, as a result of Sepsis-3, a defining feature of septic shock. […] The Sepsis-3 task force recommend use of a formal assessment of organ dysfunction known as Sequential [Sepsis-related] Organ Failure (SOFA). […] The role of traditional microbiological culture is limited in the context of sepsis diagnosis because of inevitable time delay involved. […] Acknowledging the limitation of microbiological culture, the authors devote most of this section to discussion of novel culture-independent technologies that promise rapid pathogen detection at the point of care.
  • #39 Testing for Sepsis | Sepsis Alliance
    https://www.sepsis.org/sepsis-basics/testing-for-sepsis/
    Procalcitonin (PCT): Procalcitonin is a protein in your blood that rises if you have a bacterial infection. It cannot tell what type of bacterial infection you may have. If you have low levels of PCT, your doctor may rule out a bacterial infection. […] The symptoms of early sepsis are vague and often easily dismissed.
  • #40 Diagnosing & Treating Sepsis: The Need for Speed | bioMérieux Living Diagnostics Blog
    https://www.biomerieux.com/corp/en/blog/sepsis/Diagnosing-Treating-Sepsis-Need-Speed.html
    Reducing deaths from sepsis is directly dependent on identifying sepsis early and quickly beginning appropriate antimicrobial treatment. Fast and accurate diagnosis may also shorten the length of a hospital stay for patients and reduce the emergence of bacteria that are resistant to multiple antibiotics. […] Both early diagnosis and prompt administration of antimicrobial therapy are crucial for treating sepsis and saving lives. […] Efficient sepsis diagnosis and treatment are crucial in the fight against AMR. […] PCT can help clinicians evaluate whether a patient has sepsis, and if so, begin antimicrobial therapy. […] Laboratory technicians can then follow identification with antibiotic susceptibility testing to help the clinician select more appropriate antibiotic therapy if necessary.
  • #41 Diagnosing & Treating Sepsis: The Need for Speed | bioMérieux Living Diagnostics Blog
    https://www.biomerieux.com/corp/en/blog/sepsis/Diagnosing-Treating-Sepsis-Need-Speed.html
    Throughout this process, periodically checking PCT levels can help clinicians monitor whether treatment is working and decide when it is safe to stop antibiotic therapy. […] Ultimately, as many as 80% of sepsis deaths could be prevented through early identification and swift initiation of appropriate treatment.
  • #42 Sepsis Solutions | Pioneering Diagnostics
    https://www.biomerieux.com/us/en/our-offer/in-hospital-in-lab/sepsis-solutions.html
    Identifying sepsis risk as quickly as possible is critical for immediate treatment. […] Sepsis may be diagnosed too late because the clinical symptoms, including high fever and increased pulse or respiratory rate, are non-specific. […] Measuring procalcitonin levels with VIDAS BRAHMS PCT gives an early indication of severe bacterial infection in about 20 minutes. […] Clinicians can use this information when deciding empiric antimicrobial therapy, which in turn helps reduce the risk of injury and death. […] After initial risk assessment and administration of empiric therapy, pathogen detection, identification, and susceptibility testing provide critical information about whether the initial therapy needs to be adjusted. […] To optimize patient outcomes, physicians need to monitor patients for complications and for response to treatment.
  • #43 In search of better biomarkers to support sepsis diagnosis
    https://www.sysmex.se/academy/knowledge-centre/expert-voices/haematology/in-search-of-better-biomarkers-to-support-sepsis-diagnosis/
    In search of better biomarkers to support sepsis diagnosis […] The concept of WBC activation parameters was also new for me, so I began studying the technical basis and tried to verify the potential value based on our daily workload. […] Fast and appropriate therapy is a cornerstone when it comes to sepsis. However, the discrimination of sepsis from non-infectious causes of inflammation may be difficult, and biomarkers have been suggested to aid physicians in this decision. Procalcitonin (PCT) is currently the most frequently recommended biomarker for this purpose. […] A quick initial indication would be beneficial since this can point out the appropriate diagnostic tests while avoiding unnecessary follow-up tests, and help start treatment faster, which is essential in septic patients.
  • #44 Why Better Sepsis Diagnosis Results in Better Outcomes |
    https://clpmag.com/disease-states/sepsis/why-better-sepsis-diagnosis-results-in-better-outcomes/
    Given the limitations of blood culture and pathogen identification methods for diagnosing sepsis, and the fact that the new definition of sepsis includes a dysregulated host immune response to infection, many researchers have explored the utility of diagnostics based on measuring host immune response biomarkers. […] A handful of well-established biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT) present desirable characteristic for biomarkers, i.e., immediate description of the current status of the host response of the patient, but discordances in their diagnostic and prognostic performance create the need toward a holistic approach to sepsis diagnostics, including a combination of clinical signs and symptoms, sepsis biomarkers, and microbiological tests. […] A more recent innovative approach to sepsis diagnosis is measurement of gene expression using Polymerase Chain Reaction (PCR) using a patients blood sample.
  • #45 In search of better biomarkers to support sepsis diagnosis
    https://www.sysmex.se/academy/knowledge-centre/expert-voices/haematology/in-search-of-better-biomarkers-to-support-sepsis-diagnosis/
    Biomarkers can be applied to diagnosis, prognosis, and therapy monitoring. […] Other biomarkers, such as C-reactive protein (CRP), or interleukin 6 (IL-6) have been proposed to diagnose sepsis or to predict mortality, but they currently lack sufficient sensitivity and specificity to be considered for stand-alone testing. […] The second essential contribution that laboratory medicine could provide in sepsis-related diagnostics encompasses staging, prognostication, and therapeutic monitoring. […] Therefore, the use of innovative, easily accessible, and virtually inexpensive parameters represents an appealing perspective for improving the clinical outcome in septic patients. […] Ultimately, the goal is to improve patient care through early detection supported by rapid-response laboratory confirmation and immediate treatment.
  • #46
    https://healthmanagement.org/c/icu/IssueArticle/sepsis-diagnosis-clinical-signs-scores-and-biomarkers
    The diagnosis and management of sepsis are based on criteria and algorithms published in international guidelines. […] In adults and in children, the diagnosis of sepsis is based on an early diagnosis of a bacterial infection and the identification of a dysregulated response of the body with organ dysfunction. […] In the case of (suspected) sepsis, it is recommended to confirm or rule out bacterial infection and to continuously reassess the infectious diagnosis, to initiate, modify or stop antibiotic therapy. […] Biomarkers have been extensively studied to help diagnose rapid bacterial infection in patients with suspected sepsis. […] Therefore, we believe biomarkers may be a useful addition to the current diagnosis based on clinical signs and scores. […] The diagnosis of dysregulated response of the body is based on SIRS criteria and/or organ dysfunction according to the SSC 2021 guidelines.
  • #47 Testing for Sepsis | Sepsis Alliance
    https://www.sepsis.org/sepsis-basics/testing-for-sepsis/
    Unlike diseases or conditions like diabetes or kidney stones, there is no one test for sepsis. However, your doctor makes the diagnosis by evaluating your symptoms, your history, and other tests. This can then lead your doctor to suspect you have sepsis. […] None of these tests can diagnose sepsis, but when the test results are combined with information about your illness and a physical examination, they can help your doctor determine if you have sepsis: […] The following tests are what doctors call confirmatory or diagnostic tests. The test results give the medical team more information when they suspect sepsis. […] If your doctor suspects sepsis, treatment (with fluids and antibiotics) should begin right away, while waiting for these confirmatory test results. […] Endotoxin is a component of certain bacteria, released when the bacteria cell disintegrates. It should not be in your blood, so its presence confirms there are gram negative bacteria in your bloodstream, although this test cannot identify which type.
  • #48 Diagnosis of sepsis: which clinical and laboratory biomarkers are useful? – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16878/
    An ideal biomarker should demonstrate high sensitivity and specificity, be suitable for bedside use, and remain cost-effective. […] Although hundreds of biomarkers show diagnostic and prognostic potential in sepsis, their routine clinical application remains limited. […] The following overview describes the tests currently used in routine clinical practice in our hospitals. […] The selection of biomarkers listed below is based on our experiences over the past 30 years. […] In current practice, generally, the most critical factor for these biomarkers is not their absolute value but rather the trend reflecting how values change over the course of sepsis. […] The sensitivity of these scoring systems ranges from 42% to 84%, and their specificity varies between 54% and 82%. […] The efficacy of the existing scoring systems for identifying sepsis may be markedly improved by incorporating additional blood markers of inflammation (C-reactive protein [CRP], neutrophil-to-lymphocyte ratio [NLR], PCT), shock (N-terminal proB-type natriuretic peptide [NT-proBNP]), and metabolic acidosis (pH, lactate).
  • #49 In search of better biomarkers to support sepsis diagnosis
    https://www.sysmex.se/academy/knowledge-centre/expert-voices/haematology/in-search-of-better-biomarkers-to-support-sepsis-diagnosis/
    The clinical application of WBC activation parameters offers several advantages. […] We wanted to evaluate the potential contribution of white blood cell activation parameters to improve the detection of patients at risk of developing sepsis. […] Our objective was to develop predictive models and clinical prediction rules based on WBC activation parameter values that allow sepsis to be detected early with a good diagnostic performance, and to that end we composed a score (NEMO, neutrophils and monocytes), a risk score for sepsis. […] The NEMO score includes WBC activation parameter values for neutrophils and monocytes characterizing the early innate immune response. […] The most relevant parameters (NEUT-RI and MONO-X) were selected to be included in the NEMO score to stratify the risk of suffering from sepsis.
  • #50 Diagnosis of sepsis: which clinical and laboratory biomarkers are useful? – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16878/
    An ideal biomarker should demonstrate high sensitivity and specificity, be suitable for bedside use, and remain cost-effective. […] Although hundreds of biomarkers show diagnostic and prognostic potential in sepsis, their routine clinical application remains limited. […] The following overview describes the tests currently used in routine clinical practice in our hospitals. […] The selection of biomarkers listed below is based on our experiences over the past 30 years. […] In current practice, generally, the most critical factor for these biomarkers is not their absolute value but rather the trend reflecting how values change over the course of sepsis. […] The sensitivity of these scoring systems ranges from 42% to 84%, and their specificity varies between 54% and 82%. […] The efficacy of the existing scoring systems for identifying sepsis may be markedly improved by incorporating additional blood markers of inflammation (C-reactive protein [CRP], neutrophil-to-lymphocyte ratio [NLR], PCT), shock (N-terminal proB-type natriuretic peptide [NT-proBNP]), and metabolic acidosis (pH, lactate).
  • #51 Diagnosis of neonatal sepsis: the past, present and future | Pediatric Research
    https://www.nature.com/articles/s41390-021-01696-z
    An ideal marker should have sensitivity and negative predictive value (NPV) approaching 100%; specificity and positive predictive value (PPV) over 85%. […] None of the biomarkers or combination of biomarkers have adequate diagnostic accuracy to be used reliably in the diagnosis of neonatal sepsis. […] Traditional methods of blood cultures have changed to automated blood culture monitoring for bacterial growth by CO2 detection. Newer tests involve rapidly identifying organisms from positive cultures by fluorescent in situ hybridization techniques. Molecular microbiological diagnostics using PCR for bacterial and fungal genes can be applied directly to blood specimens. Inflammatory biomarkers including CRP, procalcitonin, and cytokines are another category of adjunctive diagnostic tests.
  • #52 Bacterial Sepsis Workup: Approach Considerations, Laboratory Studies, Chest Radiology and Chest CT Scan
    https://emedicine.medscape.com/article/234587-workup
    Multiple clinical, laboratory, radiologic, and microbiologic data are required for the diagnosis of sepsis and septic shock. Sepsis should never be diagnosed based on a single abnormality. However, the diagnosis is often made empirically at the bedside upon presentation or retrospectively when follow-up data return (eg, positive blood culture result) or a response to antibiotics is evident. Importantly, the identification of a pathogenic organism, although preferred, is not always feasible since the responsible organism may be unidentified in many patients. […] In general, the workup for sepsis may include the following: Blood culture and urine analysis and culture; Chemistry studies that can suggest organ dysfunction, such as liver or kidney function tests; Serum lactate levels obtained urgently and serially; Chest radiology; Diagnostic imaging of the chest and abdomen/pelvis; Cardiac studies such as ECG and troponins, as indicated; Interventions such as paracentesis, thoracentesis, lumbar puncture, or aspiration of an abscess, as clinically indicated; Measurement of biomarkers of sepsis such as procalcitonin levels.
  • #53 Sepsis Diagnosis Gets Point-of-Care Solution | Clinical Lab Products
    https://clpmag.com/disease-states/sepsis/sepsis-diagnosis-gets-point-of-care-solution/
    Sepsis Diagnosis Gets Point-of-Care Solution […] Magnolia Medicals Steripath delivers critical time savings for sepsis diagnosis, improving patient outcomes and providing cost efficiencies for health care providers. […] With sepsis time is of the essence. Each hour delay in treatment increases patient mortality by 4% to 9%. Thats why fast and effective sepsis diagnosis is critical. […] Magnolia Medicals Steripath is a point-of-care solution thats designed to be sensitive and fast, giving clinicians and patients time for sepsis diagnosis and treatment. […] Blood cultures are the gold standard test for diagnosing blood stream infections, including sepsis. […] False positives are a preventable error that can lead to a misdiagnosis of sepsis. […] Steripath addresses both controllable and uncontrollable factors of blood culture contamination and solves the problem at its source by preventing a contamination so there is no potential contaminated blood culture for the bedside clinician to react to and no clinical decision dilemma to continue or discontinue antibiotics.
  • #54 Sepsis | Choose the Right Test
    https://arupconsult.com/content/sepsis
    Increases in serum lactate concentrations are associated with a higher risk of developing overt septic shock and poor outcome in general. An initial measurement of serum lactate is recommended to guide resuscitation. […] Two sets of blood cultures (each set including both aerobic and anaerobic bottles) should be obtained from two different sites before administering antibiotics to ensure accurate identification of pathogens and proper medical management of infection. […] Procalcitonin (PCT) is an acute phase reactant (inflammatory marker) that is used as a biomarker for the risk assessment of progression to severe sepsis or septic shock and can help inform decisions on the duration of antibiotic treatment. Initial PCT concentrations on the first day of admission to the intensive care unit (ICU) may be used to aid in the assessment of risk for progression to severe sepsis and septic shock. A PCT concentration should be taken shortly after admission to the ICU to establish a baseline to monitor treatment response.
  • #55 Don’t miss the diagnosis of sepsis! | Critical Care | Full Text
    https://ccforum.biomedcentral.com/articles/10.1186/s13054-014-0529-6
    Blood cultures are considered the clinical gold standard for the diagnosis of bacterial infections. However, blood cultures are only positive in 20 to 30% of patients with sepsis; moreover, it takes 2 to 3 days before the results become available. […] Several biomarkers have been developed to assist in the early diagnosis of sepsis, including procalcitonin (PCT), C-reactive protein (CRP) and, more recently, circulating cell-free DNA (cfDNA). […] The use of PCT for the diagnosis of sepsis is controversial; however, clinical studies suggest that PCT is currently the most useful biomarker to aid in its diagnosis. […] It is important to emphasize that the PCT assay can yield both false positive and false negative results. Furthermore, there is no perfect sepsis test. The diagnosis of sepsis requires a high index of suspicion. […] When the diagnosis of sepsis is not clear we recommend a complete blood count with differential, blood lactate level and PCT as well as appropriate bacteriological cultures.
  • #56 Don’t miss the diagnosis of sepsis! | Critical Care | Full Text
    https://ccforum.biomedcentral.com/articles/10.1186/s13054-014-0529-6
    Blood cultures are considered the clinical gold standard for the diagnosis of bacterial infections. However, blood cultures are only positive in 20 to 30% of patients with sepsis; moreover, it takes 2 to 3 days before the results become available. […] Several biomarkers have been developed to assist in the early diagnosis of sepsis, including procalcitonin (PCT), C-reactive protein (CRP) and, more recently, circulating cell-free DNA (cfDNA). […] The use of PCT for the diagnosis of sepsis is controversial; however, clinical studies suggest that PCT is currently the most useful biomarker to aid in its diagnosis. […] It is important to emphasize that the PCT assay can yield both false positive and false negative results. Furthermore, there is no perfect sepsis test. The diagnosis of sepsis requires a high index of suspicion. […] When the diagnosis of sepsis is not clear we recommend a complete blood count with differential, blood lactate level and PCT as well as appropriate bacteriological cultures.
  • #57 Machine Learning Enables Diagnosis of Sepsis, the Elusive Global Killer | UC San Francisco
    https://www.ucsf.edu/news/2022/10/424116/machine-learning-enables-diagnosis-sepsis-elusive-global-killer
    Current sepsis diagnostics focus on detecting bacteria by growing them in culture, a process that is essential for appropriate antibiotic therapy, which is critical for sepsis survival, according to the researchers behind the new method. […] This results in clinicians being unable to identify the cause of sepsis in an estimated 30 to 50% of cases, Langelier said. […] In the absence of a definitive diagnosis, doctors often prescribe a cocktail of antibiotics in an effort to stop the infection, but the overuse of antibiotics has led to increased antibiotic resistance worldwide. […] However, detecting and identifying the presence of a pathogen alone isnt enough for accurate sepsis diagnosis, so the Biohub researchers also performed transcriptional profiling which quantifies gene expression to capture the patients response to infection.
  • #58 Bacterial Sepsis: Practice Essentials, Background, Etiology
    https://emedicine.medscape.com/article/234587-overview
    A diagnosis of sepsis is based on a detailed history, physical examination, laboratory and microbiology testing, and imaging studies. Laboratory studies that may be considered include the following: Complete blood count (CBC) – May show elevated or low white blood cell count, anemia, and/or thrombocytopenia; Chemistry studies, such as markers of liver or kidney injury – May suggest organ dysfunction; Bacterial cultures – Blood cultures and site-specific cultures based on clinical suspicion (eg, wound culture, sputum culture, or urine culture); Stained buffy coat smears or Gram staining of peripheral blood – May be helpful in certain infections; Urine studies (urinalysis, microscopy, urine culture); Certain biomarkers, such as procalcitonin and presepsin – May be useful in diagnosing early sepsis and in determining prognosis. […] Early identification scores, including NEWS, Modified Early Warning Score (MEWS), and SIRS, demonstrate greater reliability and predictive capability compared to the qSOFA.
  • #59 Fast Track Diagnostic Tools for Clinical Management of Sepsis: Paradigm Shift from Conventional to Advanced Methods
    https://www.mdpi.com/2075-4418/13/2/277
    The current review discusses the present status of conventional, modern and advanced methods along with their advantages and disadvantages in the deep specialized, translational and application-related scope. […] The detection of pathogens using these techniques is based on the apparent growth of microorganisms on a suitable culture media. […] For detection as well as identification of causative pathogens, sampling of blood/urine/lavage from patients, their routine culture followed by the Gram staining test remains the gold standard method. […] The following are the three main issues with using this culture-based method: Firstly, the conventional microbiological tests require 5 days to detect and identify the pathogens involved in sepsis. […] The technology has been updated to expand the usage of traditional PCR.
  • #60
    https://link.springer.com/article/10.1007/s00134-024-07428-1
    Metagenomic next-generation sequencing (mNGS) is a more recent innovation that can detect all nucleic acid fragments within a sample. These fragments are sequenced simultaneously, analysed and compared to a reference database to identify any organismal DNA present, covering bacteria, fungi, viruses and parasites and independent of taxonomy. Recent studies in respiratory and blood samples indicate the clinical potential of this technique with a significant increase in diagnostic yield. […] A recent multicentre study identified a small panel of host-response gene transcripts that could predict postoperative infection and sepsis with good accuracy up to three days before clinical symptoms. This finding needs to be prospectively validated in different patient populations but highlights the fact that infection and sepsis rarely develop within hours but brew over several days, providing the opportunity for presymptomatic diagnosis and early targeted intervention.
  • #61 Fast Track Diagnostic Tools for Clinical Management of Sepsis: Paradigm Shift from Conventional to Advanced Methods
    https://www.mdpi.com/2075-4418/13/2/277
    Despite several advances, high-throughput science research laboratories can redirect standard PCR methods, including nested PCR techniques, due to the immense exposure of excess contamination with amplified products. […] Surface-enhanced Raman spectroscopy (SERS) is emerging as an important technology for the identification which amplifies the Raman dispersing of the objective particles on a superficial layer of metal made of graphene or other different materials. […] Matrix-assisted laser desorption ionization-time of flight mass spectroscopy (MALDI-TOF-MS) is another newly discovered procedure that is now being used in clinical research to detect bacterial species. […] The currently employed technique to detect AMR is time taking (3 to 5 days) and hampers the clinical management of sepsis results in a poor outcome.
  • #62 Fast Track Diagnostic Tools for Clinical Management of Sepsis: Paradigm Shift from Conventional to Advanced Methods
    https://www.mdpi.com/2075-4418/13/2/277
    Despite several advances, high-throughput science research laboratories can redirect standard PCR methods, including nested PCR techniques, due to the immense exposure of excess contamination with amplified products. […] Surface-enhanced Raman spectroscopy (SERS) is emerging as an important technology for the identification which amplifies the Raman dispersing of the objective particles on a superficial layer of metal made of graphene or other different materials. […] Matrix-assisted laser desorption ionization-time of flight mass spectroscopy (MALDI-TOF-MS) is another newly discovered procedure that is now being used in clinical research to detect bacterial species. […] The currently employed technique to detect AMR is time taking (3 to 5 days) and hampers the clinical management of sepsis results in a poor outcome.
  • #63 Bacterial Sepsis Workup: Approach Considerations, Laboratory Studies, Chest Radiology and Chest CT Scan
    https://emedicine.medscape.com/article/234587-workup
    Multiple clinical, laboratory, radiologic, and microbiologic data are required for the diagnosis of sepsis and septic shock. Sepsis should never be diagnosed based on a single abnormality. However, the diagnosis is often made empirically at the bedside upon presentation or retrospectively when follow-up data return (eg, positive blood culture result) or a response to antibiotics is evident. Importantly, the identification of a pathogenic organism, although preferred, is not always feasible since the responsible organism may be unidentified in many patients. […] In general, the workup for sepsis may include the following: Blood culture and urine analysis and culture; Chemistry studies that can suggest organ dysfunction, such as liver or kidney function tests; Serum lactate levels obtained urgently and serially; Chest radiology; Diagnostic imaging of the chest and abdomen/pelvis; Cardiac studies such as ECG and troponins, as indicated; Interventions such as paracentesis, thoracentesis, lumbar puncture, or aspiration of an abscess, as clinically indicated; Measurement of biomarkers of sepsis such as procalcitonin levels.
  • #64 Bacterial Sepsis Workup: Approach Considerations, Laboratory Studies, Chest Radiology and Chest CT Scan
    https://emedicine.medscape.com/article/234587-workup
    Multiple clinical, laboratory, radiologic, and microbiologic data are required for the diagnosis of sepsis and septic shock. Sepsis should never be diagnosed based on a single abnormality. However, the diagnosis is often made empirically at the bedside upon presentation or retrospectively when follow-up data return (eg, positive blood culture result) or a response to antibiotics is evident. Importantly, the identification of a pathogenic organism, although preferred, is not always feasible since the responsible organism may be unidentified in many patients. […] In general, the workup for sepsis may include the following: Blood culture and urine analysis and culture; Chemistry studies that can suggest organ dysfunction, such as liver or kidney function tests; Serum lactate levels obtained urgently and serially; Chest radiology; Diagnostic imaging of the chest and abdomen/pelvis; Cardiac studies such as ECG and troponins, as indicated; Interventions such as paracentesis, thoracentesis, lumbar puncture, or aspiration of an abscess, as clinically indicated; Measurement of biomarkers of sepsis such as procalcitonin levels.
  • #65 Sepsis – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/sepsis/diagnosis-treatment/drc-20351219
    Doctors often order several tests to try to pinpoint underlying infection. […] Blood samples are used to test for: […] Other lab tests to find the source of the infection might include samples of: […] If the site of infection is not readily found, your health care provider may order more tests. […] Treatment with antibiotics begins as soon as possible. […] Different medications are used in treating sepsis and septic shock. […] People who have sepsis often get supportive care that includes oxygen. […] Surgery may help to remove sources of infection, such as pus, infected tissues or dead tissues. […] Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.
  • #66 Sepsis – Wikipedia
    https://en.wikipedia.org/wiki/Sepsis
    Within twelve hours, it is essential to diagnose or exclude any source of infection that would require emergent source control, such as a necrotizing soft tissue infection, an infection causing inflammation of the abdominal cavity lining, an infection of the bile duct, or an intestinal infarction. […] The definition of SIRS is shown below: SIRS is the presence of two or more of the following: abnormal body temperature, heart rate, respiratory rate, or blood gas, and white blood cell count. […] Sepsis is defined as SIRS in response to an infectious process. […] Severe sepsis is defined as sepsis with sepsis-induced organ dysfunction or tissue hypoperfusion (manifesting as hypotension, elevated lactate, or decreased urine output). […] Septic shock is severe sepsis plus persistently low blood pressure, despite the administration of intravenous fluids.
  • #67 Azthena logo with the word Azthena
    https://www.news-medical.net/health/Sepsis-Diagnosis.aspx
    Some of the different tests that are needed to make a sepsis diagnosis include a urine test, blood test, and tests related to other medical conditions. […] For patients with possible signs of sepsis, there are a number of blood tests that can be utilized. Even though these tests cannot diagnose sepsis, combining the results with other information can help. […] There are three types of blood tests that can confirm sepsis, which include: Endotoxin test, Procalcitonin (PCT) test, SeptiCyte test. […] Two types of urine tests are ordered in cases of sepsis, which include: Urinalysis, Urine culture. […] Apart from blood and urine tests, additional tests that are related to other diseases that can cause sepsis are also performed.
  • #68 About SeptiCyte® – Immunexpress
    https://immunexpress.com/products/
    SeptiCyte® RAPID enhances sepsis diagnosis and treatment by analyzing immune cells’ RNA, which offers a measurable snapshot of the host’s immune response. […] Our algorithm quantifies the patient’s immune response to sepsis and rapidly provides actionable clinical information in 100% of suspected sepsis cases. […] SeptiCyte® RAPID was developed to empower clinicians to provide the most effective sepsis care management, by using specific biomarkers in the patient’s immune system to measure dysregulated immune response signals that indicate sepsis. […] SeptiCyte® RAPID has CE mark for Europe, TGA for Australia and received FDA market clearance as the first one hour direct from blood sepsis test. […] SeptiCyte® RAPID achieves this with high accuracy and superior performance to clinical parameters and other lab tests.
  • #69 Why Better Sepsis Diagnosis Results in Better Outcomes |
    https://clpmag.com/disease-states/sepsis/why-better-sepsis-diagnosis-results-in-better-outcomes/
    SeptiCyte RAPID measures host response to differentiate sepsis from non-infectious systemic inflammation (i.e., SIRS). […] SeptiCyte RAPID provides high sensitivity (0.94) and high specificity (0.90) for cases with low and high SeptiScores, respectively. […] Because of the short turnaround time and high accuracy, SeptiCyte RAPID has the potential to improve clinicians diagnostic and therapeutic stewardship. […] To overcome these challenges, not only is it important to have rapid and accurate diagnosis of sepsis, but being able to stratify patients showing clinical signs of systemic inflammatory response without any infection is also equally crucial. […] The adoption of innovative approaches, such as SeptiCyte RAPID, to aid in sepsis diagnosis is expected to provide benefits to patients, clinical utility to physicians and financial benefits to hospital and health systems.
  • #70 Machine Learning Enables Diagnosis of Sepsis, the Elusive Global Killer | UC San Francisco
    https://www.ucsf.edu/news/2022/10/424116/machine-learning-enables-diagnosis-sepsis-elusive-global-killer
    The researchers found that the mNGS method and their corresponding model worked better than expected: They were able to identify 99% of confirmed bacterial sepsis cases, 92% of confirmed viral sepsis cases, and were able to predict sepsis in 74% of clinically suspected cases that hadnt been definitively diagnosed. […] By using this approach, we get a pretty good idea of what is causing the disease, and we know with relatively high confidence if a patient has sepsis or not. […] The team was also excited to discover that they could use this combined host-response and microbe detection method to diagnose sepsis using plasma samples, which are routinely collected from most patients as part of standard clinical care. […] The idea for the work stemmed from previous research by Langelier, Kalantar, Calfee, UCSF researcher and CZ Biohub President Joe DeRisi, PhD, and their colleagues, in which they used mNGS to effectively diagnose lower respiratory tract infections in critically ill patients. […] If we can do that, its the first step towards precision medicine and understanding whats going on at an individual patient level.
  • #71 Precision Medicine in Sepsis Diagnosis – The Hospitalist
    https://www.the-hospitalist.org/hospitalist/article/37657/critical-care/precision-medicine-in-sepsis-diagnosis/
    Epigenomics is a rapidly expanding field exploring heritable changes in gene expression due to the environment, allostatic load, and other external factors that do not alter DNA sequencing and could explain the variability in gene expression during sepsis. Investigations into various microRNAs, an epigenetic marker, indicate their expression is linked to sepsis-associated encephalopathy, acute lung injury, acute kidney injury, and endothelial leakage, suggesting that these could be potential targets for therapeutic development. […] Transcriptomics analyzes and monitors RNA transcription to gain insights into regulatory mechanisms, disease pathways, and therapeutic targets. This field has helped identify several different sepsis phenotypes and endotypes. Moreover, it is established that gene expression endotypes observed on day one differ from those on day three among half of adult septic patients.
  • #72 Precision Medicine in Sepsis Diagnosis – The Hospitalist
    https://www.the-hospitalist.org/hospitalist/article/37657/critical-care/precision-medicine-in-sepsis-diagnosis/
    Two recent studies are advancing rapid sepsis diagnosis. The first study categorized suspected sepsis patients into five endotypes based on unique gene expression within two hours of their arrival in the emergency department, showing varying outcomes. The second study introduced a rapid testing system with a one-hour turnaround time, using four host immune markers to diagnose sepsis. […] Several biomarkers have been used to identify and differentiate patients with sepsis. Guidelines caution about the risks of false positives and negatives when using procalcitonin (PCT), emphasizing the need for careful interpretation of results in the appropriate clinical context. C-reactive protein (CRP) is another biomarker used to assess for sepsis. […] Cell-free DNA techniques have enhanced the care of septic patients by enabling rapid diagnosis of sepsis-causing pathogens along with their antibiotic-resistance profiles compared to standard blood culture methods. […] In summary, precision medicine accelerates the process of obtaining crucial information about hosts, genes, and microbes from days to just hours, enhancing patient care by customizing treatment. This strategy targets reduced antimicrobial resistance, patient morbidity, and healthcare costs.
  • #73 IntelliSep Sepsis Test – Cytovale
    https://cytovale.com/our-solution/intellisep-sepsis-test/
    Sepsis is a Medical Emergency that is Common, Costly, and Difficult to Diagnose. Misdiagnosis and delayed treatment may lead to serious consequences for patients and hospitals. 80% of sepsis deaths could be prevented with a rapid sepsis test that aids in sepsis diagnosis. […] Unlike Other Time-Sensitive Medical Emergencies, Sepsis Lacked a Highly Sensitive Diagnostic Test. Until Now. Like heart attack and stroke, there is now an objective detection tool for sepsis, supporting rapid diagnosis and treatment. […] IntelliSep is an In Vitro Diagnostic Test for Sepsis with Clear, Actionable Results. In about 8 minutes IntelliSep delivers clinically actionable results, risk-stratifying patients based on their probability of having sepsis. Results are presented as a numerical value between 0.1 and 10.0, which is further stratified into 3 discrete bands. Patients with sepsis typically have higher scores and fall into Band 3. IntelliSep helps the ED accelerate the time to diagnosis and treatment, patient disposition, and throughput.
  • #74 Sepsis Symptoms, Diagnosis and Treatment | Froedtert & MCW
    https://www.froedtert.com/emergency/sepsis-testing-symptoms
    Sepsis, also known as septicemia (or blood poisoning), happens when an infection thats unidentified or untreated spreads through the blood stream. […] The Emergency Department at Froedtert Hospital uses a lab test called Intellisep to help find sepsis when doctors suspect a patient has an infection and possible sepsis. […] The test involves a simple blood draw. Then, in a lab, white blood cells are quickly and accurately analyzed for the probability of sepsis infection. […] Armed with this information, emergency room doctors and clinicians can make life-saving treatment decisions. […] If sepsis is discovered, it can be treated with antibiotics and fluids. […] Where IntelliSep isnt available, emergency room doctors can still diagnose and treat sepsis. […] If your doctor suspects sepsis, an appropriate treatment plan will be recommended.
  • #75 Sepsis Diagnosis: A Guide To Early Detection & Testing
    https://www.babirus.ae/sepsis-diagnosis-a-guide-to-early-detection/
    Given its complex nature, no single test can confirm sepsis on its own. […] Traditional blood cultures remain the gold standard for detecting bloodstream infections associated with sepsis. […] Sepsis biomarkers are measurable substances in the blood that indicate infection and inflammation. […] With advances in molecular testing, rapid sepsis detection is now possible within hours instead of days. […] Point-of-care biomarker tests allow for quick screening in emergency and intensive care settings, reducing the time needed to initiate life-saving treatment. […] Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry is a valuable tool in identifying bacteria and fungi in suspected sepsis cases. […] Despite advancements in diagnostics, sepsis remains difficult to detect early, primarily due to non-specific symptoms.
  • #76 Sepsis Solutions | Pioneering Diagnostics
    https://www.biomerieux.com/us/en/our-offer/in-hospital-in-lab/sepsis-solutions.html
    Identifying sepsis risk as quickly as possible is critical for immediate treatment. […] Sepsis may be diagnosed too late because the clinical symptoms, including high fever and increased pulse or respiratory rate, are non-specific. […] Measuring procalcitonin levels with VIDAS BRAHMS PCT gives an early indication of severe bacterial infection in about 20 minutes. […] Clinicians can use this information when deciding empiric antimicrobial therapy, which in turn helps reduce the risk of injury and death. […] After initial risk assessment and administration of empiric therapy, pathogen detection, identification, and susceptibility testing provide critical information about whether the initial therapy needs to be adjusted. […] To optimize patient outcomes, physicians need to monitor patients for complications and for response to treatment.
  • #77 FDA-approved AI-driven tool for sepsis diagnosis – Bioanalysis Zone
    https://www.bioanalysis-zone.com/fda-approved-ai-driven-tool-for-sepsis-diagnosis/
    Another artificial intelligence (AI)-driven tool approval is in the bag, this time for sepsis diagnosis. The test, Sepsis ImmunoScore, is the first AI diagnostic tool for sepsis to receive the FDAs go-ahead. […] Sepsis can be challenging to diagnose immediately, particularly in critically ill patients. […] The FDAs authorization of Sepsis ImmunoScore represents a significant milestone in this process. […] FDA authorization of a sepsis diagnostic tool with significant predictive power is a landmark event for people that could ever be at risk of sepsis at some point in their lives, commented Bobby Reddy, Prenosis Co-Founder and CEO. Until now, there was no other FDA-authorized AI diagnostic for sepsis, which is why the Sepsis ImmunoScoreTM had to be granted marketing authorization through the De Novo pathway. FDA authorization offers yet another important piece of evidence of the potential of the Sepsis ImmunoScoreTM to improve care. […] After successfully showcasing the safety and efficacy of Sepsis ImmunoScore to the FDA over 18 months and subsequently securing approval, Prenosis plans to conduct further studies to validate the accuracy and impact of the Sepsis ImmunoScore on clinical decision-making.
  • #78 Sepsis Diagnosis: A Guide To Early Detection & Testing
    https://www.babirus.ae/sepsis-diagnosis-a-guide-to-early-detection/
    Given its complex nature, no single test can confirm sepsis on its own. […] Traditional blood cultures remain the gold standard for detecting bloodstream infections associated with sepsis. […] Sepsis biomarkers are measurable substances in the blood that indicate infection and inflammation. […] With advances in molecular testing, rapid sepsis detection is now possible within hours instead of days. […] Point-of-care biomarker tests allow for quick screening in emergency and intensive care settings, reducing the time needed to initiate life-saving treatment. […] Matrix-Assisted Laser Desorption/Ionization Time-of-Flight (MALDI-TOF) mass spectrometry is a valuable tool in identifying bacteria and fungi in suspected sepsis cases. […] Despite advancements in diagnostics, sepsis remains difficult to detect early, primarily due to non-specific symptoms.
  • #79 Spotlight: Overdiagnosis and Delay: Challenges in Sepsis Diagnosis | PSNet
    https://psnet.ahrq.gov/web-mm/spotlight-overdiagnosis-and-delay-challenges-sepsis-diagnosis
    These criteria are more specific for sepsis but come at the expense of sensitivity, leading to concerns that many sepsis diagnoses could be delayed or missed. […] The major challenge, which none of the sepsis definitions address, is the difficulty in determining whether or not patients are infected, particularly in the early stages of presentation. […] Although procalcitonin testing can aid in the diagnosis of bacterial infection and sepsis, the test has imperfect sensitivity and specificity. […] Central to the pathophysiology of sepsis is the presence of organ dysfunction, such as hypotension, elevated lactate, respiratory failure, altered mental status, renal failure, or coagulopathy, but these are also not specific to sepsis. […] The challenges in identifying sepsis have spurred the development of various clinical decision support tools, most notably alerts that flag patients based upon real-time information in a patient’s electronic health record (EHR).
  • #80 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Sepsis should be suspected in an acutely deteriorating patient in whom there is clinical evidence or strong suspicion of infection. Have a low threshold for suspicion. […] The key to improving outcomes is early recognition and prompt treatment, as appropriate, of patients with suspected or confirmed infection who are deteriorating and at risk of organ dysfunction. By the time the diagnosis becomes obvious, with multiple abnormal physiological parameters, risk of mortality is very high. […] Ensure any patient with suspected sepsis has frequent and ongoing monitoring (e.g., using NEWS2). […] Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection. […] The definition of sepsis was updated in 2016 following publication of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
  • #81 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Sepsis should be suspected in an acutely deteriorating patient in whom there is clinical evidence or strong suspicion of infection. Have a low threshold for suspicion. […] The key to improving outcomes is early recognition and prompt treatment, as appropriate, of patients with suspected or confirmed infection who are deteriorating and at risk of organ dysfunction. By the time the diagnosis becomes obvious, with multiple abnormal physiological parameters, risk of mortality is very high. […] Ensure any patient with suspected sepsis has frequent and ongoing monitoring (e.g., using NEWS2). […] Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection. […] The definition of sepsis was updated in 2016 following publication of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
  • #82 Sepsis in adults – Symptoms, diagnosis and treatment | BMJ Best Practice
    https://bestpractice.bmj.com/topics/en-us/245
    Sepsis should be suspected in an acutely deteriorating patient in whom there is clinical evidence or strong suspicion of infection. Have a low threshold for suspicion. […] The key to improving outcomes is early recognition and prompt treatment, as appropriate, of patients with suspected or confirmed infection who are deteriorating and at risk of organ dysfunction. By the time the diagnosis becomes obvious, with multiple abnormal physiological parameters, risk of mortality is very high. […] Ensure any patient with suspected sepsis has frequent and ongoing monitoring (e.g., using NEWS2). […] Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to an infection. […] The definition of sepsis was updated in 2016 following publication of the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).
  • #83 Sepsis – Wikipedia
    https://en.wikipedia.org/wiki/Sepsis
    Sepsis requires immediate treatment with intravenous fluids and antimicrobial medications. […] Early diagnosis is necessary to properly manage sepsis, as the initiation of rapid therapy is key to reducing deaths from severe sepsis. […] Within the first three hours of suspected sepsis, diagnostic studies should include white blood cell counts, measuring serum lactate, and obtaining appropriate cultures before starting antibiotics, so long as this does not delay their use by more than 45 minutes. […] To identify the causative organism(s), at least two sets of blood cultures using bottles with media for aerobic and anaerobic organisms are necessary. […] Within six hours, if blood pressure remains low despite initial fluid resuscitation of 30 mL/kg, or if initial lactate is four mmol/L (36 mg/dL), central venous pressure and central venous oxygen saturation should be measured.
  • #84 Bacterial Sepsis Workup: Approach Considerations, Laboratory Studies, Chest Radiology and Chest CT Scan
    https://emedicine.medscape.com/article/234587-workup
    Multiple clinical, laboratory, radiologic, and microbiologic data are required for the diagnosis of sepsis and septic shock. Sepsis should never be diagnosed based on a single abnormality. However, the diagnosis is often made empirically at the bedside upon presentation or retrospectively when follow-up data return (eg, positive blood culture result) or a response to antibiotics is evident. Importantly, the identification of a pathogenic organism, although preferred, is not always feasible since the responsible organism may be unidentified in many patients. […] In general, the workup for sepsis may include the following: Blood culture and urine analysis and culture; Chemistry studies that can suggest organ dysfunction, such as liver or kidney function tests; Serum lactate levels obtained urgently and serially; Chest radiology; Diagnostic imaging of the chest and abdomen/pelvis; Cardiac studies such as ECG and troponins, as indicated; Interventions such as paracentesis, thoracentesis, lumbar puncture, or aspiration of an abscess, as clinically indicated; Measurement of biomarkers of sepsis such as procalcitonin levels.
  • #85 Sepsis | Choose the Right Test
    https://arupconsult.com/content/sepsis
    CBC, bilirubin, and creatinine tests are used in calculating SOFA scores and may help identify patients with sepsis. […] Serum lactate should be remeasured within 2-4 hours of ICU admission if initially measured concentrations exceed 2 mmol/L to guide resuscitation and normalization of lactate. Lactate may be remeasured at least 1-2 hours after starting resuscitation in patients with initially abnormal lactate concentrations; remeasuring lactate levels sooner than this does not appear to be helpful. […] PCT measurements can be used to support shortening the duration of antimicrobial therapy in patients with sepsis, bacterial pneumonia, or lower respiratory tract infections. If the optimal duration of antimicrobial therapy is unclear, PCT measurement and clinical assessment are recommended to guide the discontinuation of treatment.
  • #86 Diagnosis of sepsis: which clinical and laboratory biomarkers are useful? – Polish Archives of Internal Medicine
    https://www.mp.pl/paim/issue/article/16878/
    In the early (hyper-) acute phase of sepsis, we recommend frequent blood collection for the assessment of multiple markers of inflammation: IL-6, NLR, and PCT should be measured every 8 to 12 hours to track concentration trajectories and to check the intensity of the immune response. […] We believe that the optimal approach is to select a core set of reliable markers and effectively integrate them into clinical practice.
  • #87 Laboratory Evaluation of Sepsis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK594258/
    Identifying sepsis and septic shock can prove problematic on initial presentation. The clinical presentation of sepsis is highly variable, the differential diagnosis of sepsis is exceedingly broad, and the underlying etiology of the presenting symptoms may not be immediately evident. […] Various screening tools for sepsis are used depending on the location of the evaluation. Most of these tools utilize criteria incorporating clinical evaluation, vital signs, and laboratory data to screen for sepsis and predict mortality. Some tools commonly used to screen for sepsis include the Systemic Inflammatory Response Syndrome (SIRS) criteria, quick Sequential Organ Failure Score (qSOFA), Sequential Organ Failure Assessment (SOFA) criteria, National Early Warning Score (NEWS), and Modified Early Warning Score (MEWS).
  • #88 Why Better Sepsis Diagnosis Results in Better Outcomes |
    https://clpmag.com/disease-states/sepsis/why-better-sepsis-diagnosis-results-in-better-outcomes/
    Given the limitations of blood culture and pathogen identification methods for diagnosing sepsis, and the fact that the new definition of sepsis includes a dysregulated host immune response to infection, many researchers have explored the utility of diagnostics based on measuring host immune response biomarkers. […] A handful of well-established biomarkers such as C-reactive protein (CRP) and procalcitonin (PCT) present desirable characteristic for biomarkers, i.e., immediate description of the current status of the host response of the patient, but discordances in their diagnostic and prognostic performance create the need toward a holistic approach to sepsis diagnostics, including a combination of clinical signs and symptoms, sepsis biomarkers, and microbiological tests. […] A more recent innovative approach to sepsis diagnosis is measurement of gene expression using Polymerase Chain Reaction (PCR) using a patients blood sample.
  • #89 Understanding sepsis: The importance of biomarkers in early diagnosis | Medical Laboratory Observer
    https://www.mlo-online.com/molecular/precision-medicine/article/21287382/understanding-sepsis-the-importance-of-biomarkers-in-early-diagnosis
    Sepsis, a life-threatening organ dysfunction in response to infection, affects 4750 million people worldwide each year with approximately 11 million deaths.1 With an overall mortality rate of 1530% leading to 3050% of all in-hospital mortality.2 Early and accurate identification of sepsis is needed for successful treatment and a positive outcome.5 […] Sepsis diagnosis requires confirmation of an underlying infection through a positive blood culture, but these tests can take two to three days for results9 too long for defining a sepsis care pathway. Moreover, the overlap of clinical symptoms between sepsis and other, non-infectious inflammatory conditions can confound the diagnosis. […] The variable nature of sepsis diagnosis,21 especially early in disease, and the poor predictive value of existing criteria17 and aforementioned biomarkers highlight the importance of the availability of a unique, early sepsis biomarker to aid clinicians in escalating or de-escalating treatment for patients in the ED.
  • #90 FDA Clears First Blood Test for Sepsis
    https://www.verywellhealth.com/new-screening-test-for-sepsis-7097947
    Sepsis is a potentially fatal complication of infection. […] Sepsis can be difficult to identify early on. However, the sooner a patient is diagnosed, the better the prognosis. […] A new test may help identify patients at the highest risk of sepsis, allowing them to begin treatment sooner. […] A new test may be able to help emergency rooms identify patients with sepsis before the life-threatening condition becomes too hard to treat. […] Early diagnosis is essential because thats when clinicians can make the biggest impact. […] There is currently no test that will definitively diagnose sepsis. […] However, knowing that a patient is at a higher risk of developing sepsis can put providers on alert to be on the lookout for sepsis complications and act sooner. […] The IntelliSep test is not yet widely available in hospitals. […] If you do suspect an infection, do not delay seeking treatment. If you or a loved one develop signs of sepsis, seek immediate medical care since prompt treatment could mean the difference between life and death.
  • #91
    https://link.springer.com/article/10.1007/s00134-024-07428-1
    Diagnosing sepsis remains problematic. Pathogen identification is frequently lacking and the dysregulated host response is non-specific. Blood cultures often take days to deliver a result and, even then, approximately 90% are negative, sometimes despite strong clinical evidence of sepsis. Standard host-response biomarkers such as C-reactive protein (CRP), procalcitonin (PCT) and white cell count are routinely utilised; however, these are insufficiently discriminatory and lack specificity. This is especially challenging in the intensive care unit (ICU) setting where many patients have underlying sterile inflammation that can closely mimic clinical and laboratory features of sepsis. Despite the arrival of multiple new sepsis biomarkers over the years, none has yet achieved widespread adoption by consistently outperforming the standards.
  • #92 Laboratory diagnosis of sepsis
    https://acutecaretesting.org/en/journal-scans/laboratory-diagnosis-of-sepsis
    Sepsis and septic shock are related consequences of infection that together are a common cause of serious morbidity and high mortality around the world. […] Survival after sepsis/septic shock depends on rapid diagnosis and treatment with intense monitoring in a critical care unit. […] Sepsis is now defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. […] The additional category severe sepsis present in previous definitions was judged unhelpful by the Sepsis-3 task force, and is omitted from this most recent definition. […] It is clear from this review that a biomarker with high sensitivity and specificity for sepsis that can be assayed with speed and accuracy remains elusive. […] In 2016 there is no single laboratory test that accurately diagnoses sepsis.
  • #93
    https://diagnostics.roche.com/us/en/article-listing/health-topics/infectious-diseases/sepsis.html
    Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. […] Early sepsis diagnosis can be challenging and is critical to reducing mortality. […] It is key to identify the cause of sepsis infections early so that patients can be treated with the appropriate therapy as soon as possible to improve survival rates, reduce adverse effects of antimicrobials and reduce antimicrobial resistance. […] Rapid identification of the causative agent(s) of bloodstream infections (BSIs) is critical. […] Traditional methods can take days to identify the cause of an infection and mortality can increase up to 8% for every hour effective antibiotics are delayed. […] The rapid emergence of resistant microorganisms has led to an antibiotic resistance crisis.
  • #94 Exploring the importance and challenges of early sepsis diagnosis • healthcare-in-europe.com
    https://healthcare-in-europe.com/en/news/exploring-the-importance-challenges-of-early-sepsis-diagnosis.html
    „Additionally, it is important to note that not all tests are routinely performed for all patients, but only ordered when a clinician suspects infection or sepsis. Therefore, diagnosing sepsis early is very challenging, because symptoms may not be obvious and clear at the time at which the patient presents at the hospital.” […] „Sepsis is so complex that most probably the ideal single sepsis biomarker does not exist, and the most efficient way in early sepsis detection is the combination of several sepsis biomarkers.”
  • #95 Recognizing the Signs: How Sepsis is Diagnosed | Hackensack Meridian Health
    https://www.hackensackmeridianhealth.org/en/healthu/2024/05/09/recognizing-the-signs-how-sepsis-is-diagnosed
    It all goes back to diagnosis the faster sepsis is caught, the earlier treatment can begin and the less damage it does to the body. […] If someone experiences a mental status change – theyre not acting appropriately, feels too weak to get out of bed, is not breathing normally, or cant keep food or liquids down, its an emergency, says Dr. Fleischman.
  • #96
    https://diagnostics.roche.com/us/en/article-listing/health-topics/infectious-diseases/sepsis.html
    Sepsis is defined as life-threatening organ dysfunction caused by a dysregulated host response to infection. […] Early sepsis diagnosis can be challenging and is critical to reducing mortality. […] It is key to identify the cause of sepsis infections early so that patients can be treated with the appropriate therapy as soon as possible to improve survival rates, reduce adverse effects of antimicrobials and reduce antimicrobial resistance. […] Rapid identification of the causative agent(s) of bloodstream infections (BSIs) is critical. […] Traditional methods can take days to identify the cause of an infection and mortality can increase up to 8% for every hour effective antibiotics are delayed. […] The rapid emergence of resistant microorganisms has led to an antibiotic resistance crisis.
  • #97 Advances in sepsis diagnosis and management: a paradigm shift towards nanotechnology | Journal of Biomedical Science | Full Text
    https://jbiomedsci.biomedcentral.com/articles/10.1186/s12929-020-00702-6
    Thus, there is an urgent need for developing novel sepsis diagnostic approaches preferably adapted for accessibility for bedside diagnosis. […] An early, validated diagnostic approach is vital in the design of personalized therapeutic management plans for better clinical outcomes. […] Guidelines for sepsis management is focused on three major components (1) haemodynamic stabilization, (2) infection control, and (3) modulation of the septic responses. […] Although broad-spectrum antibiotics are integral in the management of sepsis, a major challenge associated with antibiotic therapy in sepsis is resistance by pathogens that adversely affects sepsis outcomes and increases mortality rates by approximately two-fold. […] Sepsis management requires multimodal therapeutic approaches and is based on severity.
  • #98 Sepsis Diagnosis Is Critical in the Age of Antibiotic Resistance | QuidelOrtho
    https://www.quidelortho.com/global/en/resources/articles/sepsis-diagnosis-is-critical-in-the-age-of-antibiotic-resistance
    Regardless of how it happens, when bacteria develop defenses against antibiotics in and out of the hospital, antibiotic resistance poses significant challenges to treating an infection, including infections that can lead to sepsis. […] As more germs become resistant, the risk of developing sepsis increases, because infections become harder to control and treat. […] Antibiotic stewardship refers to the strategies employed by hospitals, physicians and healthcare providers to ensure antibiotics are used appropriately and only when necessary. […] Again, this is where PCT testing plays an important role. […] By providing a quantitative measure of bacterial load, clinicians can measure the response to antibiotic treatment and, importantly, end a course of antibiotics as quickly as possible. […] Sepsis and its relationship to antibiotic resistance is a health crisis that requires the ongoing vigilance of communities and healthcare providers.
  • #99 Sepsis Management | BD
    https://www.bd.com/en-us/products-and-solutions/solutions/sepsis-management
    Mortality from septic shock increases 7.6% for every hour that treatment is delayed among patients with septic shock within the first 6 hours of onset of hypotension. The timely identification of a patient at risk for sepsis is necessary for setting the course of action to intervene with appropriate diagnosis and treatment. […] 80% of sepsis deaths could be prevented by quicker diagnosis and treatment. Decrease time to detection, followed by timely and accurate organism identification (ID) and antimicrobial susceptibility testing (AST). Reduction in transport time and faster incubation of blood cultures has been shown to reduce turnaround times and accelerate antibiotic switching. […] 5x reduction in survival when inappropriate initial antimicrobial therapy is performed for septic shock, which occurs in ~20% of patients. Ensuring that appropriate diagnostics are performed as early as possible to enable timely and appropriate antimicrobial therapy treatment decisions.
  • #100 IntelliSep Sepsis Test – Cytovale
    https://cytovale.com/our-solution/intellisep-sepsis-test/
    Sepsis is a Medical Emergency that is Common, Costly, and Difficult to Diagnose. Misdiagnosis and delayed treatment may lead to serious consequences for patients and hospitals. 80% of sepsis deaths could be prevented with a rapid sepsis test that aids in sepsis diagnosis. […] Unlike Other Time-Sensitive Medical Emergencies, Sepsis Lacked a Highly Sensitive Diagnostic Test. Until Now. Like heart attack and stroke, there is now an objective detection tool for sepsis, supporting rapid diagnosis and treatment. […] IntelliSep is an In Vitro Diagnostic Test for Sepsis with Clear, Actionable Results. In about 8 minutes IntelliSep delivers clinically actionable results, risk-stratifying patients based on their probability of having sepsis. Results are presented as a numerical value between 0.1 and 10.0, which is further stratified into 3 discrete bands. Patients with sepsis typically have higher scores and fall into Band 3. IntelliSep helps the ED accelerate the time to diagnosis and treatment, patient disposition, and throughput.
  • #101 Sepsis Solutions | Pioneering Diagnostics
    https://www.biomerieux.com/us/en/our-offer/in-hospital-in-lab/sepsis-solutions.html
    Sepsis symptoms mirror other conditions, which makes it difficult to diagnose and could lead to misdiagnosis or underdiagnosis. […] It is estimated that as many as 80% of sepsis deaths could be prevented with rapid diagnosis and appropriate treatment. […] There is no singular solution for the diagnosis of sepsis because underlying infections can be caused by different pathogens. […] Early diagnostic intelligence helps shorten the time to treatment and allows hospitals to optimize patient care with the right antimicrobial therapy at the right time. […] Diagnostics can inform sepsis care at every stage of the patient’s journey from initial presentation and risk assessment, to pathogen detection, identification, susceptibility testing, monitoring patient progress, and safe antibiotic discontinuation.
  • #102 Sepsis and Septic Shock – Critical Care Medicine – MSD Manual Professional Edition
    https://www.msdmanuals.com/professional/critical-care-medicine/sepsis-and-septic-shock/sepsis-and-septic-shock
    The SOFA score is somewhat more robust when patients are treated in the ICU, but this score requires laboratory testing. […] Following evidence-based guidelines and formal protocols for timely diagnosis and treatment of sepsis has been shown to decrease mortality and length of stay in the hospital. […] The source of infection should be controlled as early as possible. […] If the source is not controlled, the patients condition will continue to deteriorate despite antibiotic therapy. […] Overall mortality in patients with septic shock is decreasing and is about 20%. […] Poor outcomes often follow failure to institute early aggressive therapy. […] Mortality can be estimated with different scores, including the mortality in emergency department sepsis (MEDS) score.
  • #103 Sepsis – Diagnosis – Investigations – Treatment – TeachMeSurgery
    https://teachmesurgery.com/perioperative/general-complications/sepsis/
    The qSOFA score is a shortened version of the full SOFA criteria. It was developed to allow for the rapid assessment of potential sepsis, based purely on clinical signs. […] The qSOFA score permits the diagnosis of potential sepsis to be made prior to any investigations and can be completed by any healthcare professional. […] For any patient diagnosed with sepsis, immediate investigation and management steps are vital. […] These steps are commonly referred to as the sepsis six and should be completed within one hour of diagnosing sepsis: Oxygen Start 15L O2 via a non-rebreathable mask, aiming for target saturations 94-98% (or 88-92% in chronic retainers), only titrating once appropriately saturating; IV fluid therapy 500-1000mL initial fluid bolus, followed by ongoing fluid status re-assessment; Blood cultures Take blood cultures prior to administering antibiotics, along with any other relevant cultures from the suspected infection site; IV antibiotics Start empirical antibiotics (based on local guidelines), before switching to targeted therapy when sensitivities are available; Routine bloods, inc. lactate Routine bloods should include FBC, UE, LFTs, clotting, CRP, and glucose; lactate can be quickly be assessed rapidly from a blood gas; Monitor urine output Catheterise the patient if appropriate and accurately monitor urine output; aim for at least 0.5mL/kg/hour.
  • #104 Sepsis: diagnosis and management – The Pharmaceutical Journal
    https://pharmaceutical-journal.com/article/ld/sepsis-diagnosis-and-management
    Identifying the source of sepsis is essential to ensure that a patient receives optimal treatment and management of their infection. […] Some groups of people are more vulnerable to developing sepsis than others, this includes very young children (aged under 1 year old), older people (aged over 75 years old), people who are pregnant or have given birth within the past six weeks, and people who have an impaired immune system. […] Patients who are assessed as high risk should be escalated as ‘RED FLAG SEPSIS’ and should follow the ‘Sepsis Six’ pathway, a set of six tasks developed by the UK Sepsis Trust, including oxygen, cultures, antibiotics, fluids, lactate measurement and urine output monitoring to be instituted within one hour by non-specialist practitioners on the frontline. […] Delivery of the Sepsis Six ‘care bundle’ within an hour of sepsis recognition has been shown to reduce the relative risk of death by 46.6%.
  • #105 Laboratory Evaluation of Sepsis – StatPearls – NCBI Bookshelf
    https://www.ncbi.nlm.nih.gov/books/NBK594258/
    Sepsis is a medical emergency caused by organ dysfunction resulting from a dysregulated host response to an infection. Early identification and treatment of sepsis and septic shock are essential for improving outcomes. Timely initiation of antimicrobial therapy is one of the most effective interventions to reduce sepsis-related morbidity and mortality. Identifying sepsis and septic shock can be difficult due to their variable clinical presentation. Patients with suspected sepsis or septic shock are evaluated with various laboratory studies, including different biomarkers essential for diagnosis, early recognition of severity, risk stratification, and prognosis. […] Sepsis, defined by the Society of Critical Care Medicine (SCCM) Sepsis-3 criteria, is life-threatening organ dysfunction caused by a dysregulated host response to infection. Sepsis and septic shock are high causes of mortality worldwide, resulting in the death of 1 in 3 to 1 in 6 patients in whom sepsis is identified. Sepsis and septic shock are considered medical emergencies requiring time-sensitive evaluation and management; early identification and treatment initiation improve outcomes in sepsis patients. Specifically, early treatment with antimicrobial therapy is one of the most effective interventions that decreases in-hospital mortality in patients with sepsis.
  • #106 Sepsis: Diagnosis and Management | AAFP
    https://www.aafp.org/pubs/afp/issues/2020/0401/p409.html
    Guidelines published in 2016 provide a revised definition of sepsis: life-threatening organ dysfunction caused by a dysregulated host response to infection. […] The guidelines recommend the Sequential Organ Failure Assessment (original and quick versions) as an important tool for early diagnosis. […] Initial evaluation of patients with suspected sepsis includes basic laboratory tests, cultures, imaging studies as indicated, and sepsis biomarkers such as procalcitonin and lactate levels. […] The latest guidelines recommend starting antimicrobials within one hour, but this is controversial. […] Sepsis is now defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. […] Septic shock is defined as sepsis with circulatory, cellular, and metabolic dysfunction that is associated with a higher risk of mortality.
  • #107 Sepsis Management | BD
    https://www.bd.com/en-us/products-and-solutions/solutions/sepsis-management
    Mortality from septic shock increases 7.6% for every hour that treatment is delayed among patients with septic shock within the first 6 hours of onset of hypotension. The timely identification of a patient at risk for sepsis is necessary for setting the course of action to intervene with appropriate diagnosis and treatment. […] 80% of sepsis deaths could be prevented by quicker diagnosis and treatment. Decrease time to detection, followed by timely and accurate organism identification (ID) and antimicrobial susceptibility testing (AST). Reduction in transport time and faster incubation of blood cultures has been shown to reduce turnaround times and accelerate antibiotic switching. […] 5x reduction in survival when inappropriate initial antimicrobial therapy is performed for septic shock, which occurs in ~20% of patients. Ensuring that appropriate diagnostics are performed as early as possible to enable timely and appropriate antimicrobial therapy treatment decisions.
  • #108 Sepsis and Septic Shock – Critical Care Medicine – MSD Manual Professional Edition
    https://www.msdmanuals.com/professional/critical-care-medicine/sepsis-and-septic-shock/sepsis-and-septic-shock
    The SOFA score is somewhat more robust when patients are treated in the ICU, but this score requires laboratory testing. […] Following evidence-based guidelines and formal protocols for timely diagnosis and treatment of sepsis has been shown to decrease mortality and length of stay in the hospital. […] The source of infection should be controlled as early as possible. […] If the source is not controlled, the patients condition will continue to deteriorate despite antibiotic therapy. […] Overall mortality in patients with septic shock is decreasing and is about 20%. […] Poor outcomes often follow failure to institute early aggressive therapy. […] Mortality can be estimated with different scores, including the mortality in emergency department sepsis (MEDS) score.
  • #109 Sepsis and Septic Shock – Critical Care Medicine – MSD Manual Professional Edition
    https://www.msdmanuals.com/professional/critical-care-medicine/sepsis-and-septic-shock/sepsis-and-septic-shock
    The SOFA score is somewhat more robust when patients are treated in the ICU, but this score requires laboratory testing. […] Following evidence-based guidelines and formal protocols for timely diagnosis and treatment of sepsis has been shown to decrease mortality and length of stay in the hospital. […] The source of infection should be controlled as early as possible. […] If the source is not controlled, the patients condition will continue to deteriorate despite antibiotic therapy. […] Overall mortality in patients with septic shock is decreasing and is about 20%. […] Poor outcomes often follow failure to institute early aggressive therapy. […] Mortality can be estimated with different scores, including the mortality in emergency department sepsis (MEDS) score.
  • #110 Sepsis – Diagnosis & treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/sepsis/diagnosis-treatment/drc-20351219
    Doctors often order several tests to try to pinpoint underlying infection. […] Blood samples are used to test for: […] Other lab tests to find the source of the infection might include samples of: […] If the site of infection is not readily found, your health care provider may order more tests. […] Treatment with antibiotics begins as soon as possible. […] Different medications are used in treating sepsis and septic shock. […] People who have sepsis often get supportive care that includes oxygen. […] Surgery may help to remove sources of infection, such as pus, infected tissues or dead tissues. […] Explore Mayo Clinic studies testing new treatments, interventions and tests as a means to prevent, detect, treat or manage this condition.